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A. General Information. 
 Catalyst screening reactions were performed in oven-dried 1-dram vials; all other reactions were performed in oven-
dried round bottom flasks unless otherwise noted. The vials and flasks were fitted with rubber septa and reactions were 
conducted under a positive pressure of nitrogen. Stainless steel syringes or cannulae were used to transfer air- and moisture-
sensitive liquids. Flash chromatography was performed using silica gel 60 (230-400 mesh) from EM Science. Commercial 
reagents were purchased from Sigma Aldrich, Alfa Aesar, Strem, or Lancaster, and used as received with the following 
exceptions: dichloromethane, tetrahydrofuran, diethyl ether, toluene, t-butyl methyl ether and methanol were dried by passing 
through columns of activated alumina; acetonitrile and dimethylformamide were dried by passing through columns of 
activated molecular sieves. Diisopropylamine, diisopropylethylamine, triethylamine and chlorotrimethylsilane were distilled 
from CaH2 at 760 torr. n-Butyllithium and s-butyllithium were titrated following the procedure of Suffert.1 Proton nuclear 
magnetic resonance (1H NMR) spectra and carbon nuclear magnetic resonance (13C NMR) spectra were recorded on Varian-
Mercury-400 (400 MHz), Inova-500 (500 MHz), and Inova-600 (600 MHz) spectrometers. Chemical shifts for protons are 
reported in parts per million downfield from tetramethylsilane and are referenced to residual protium in the NMR solvent 
(CHCl3 = δ 7.27; C6D6 = 7.16). Chemical shifts for carbon are reported in parts per million downfield from tetramethylsilane 
and are referenced to the carbon resonances of the solvent (CDCl3 = δ 77.0; C6D6 = δ 128.6). Data are represented as follows: 
chemical shift, multiplicity (br. s = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constants 
in Hertz (Hz), integration. Infrared (IR) spectra were obtained using a Mattson Galaxy Series FTIR 3000 spectrophotometer 
referenced to a polystyrene standard. Optical rotations were measured using a 2 mL cell with a 1 dm path length on a Jasco 
DIP 370 digital polarimeter. The mass spectral data were obtained at the Harvard University mass spectrometry facility. 
Chiral gas chromatography (GC) analysis was performed on a Hewlett-Packard 5890 gas chromatograph using an Alltech 
Cyclodex β (20 m x 0.25 mm) column, chiral HPLC analysis was performed using a Shimadzu VP-series instrument.  
 
Silyl ketene acetals: Methyl trimethylsilyl dimethylketene acetal and 1-(t-butyldimethylsilyloxy)-1-methoxyethene were 
purchased from Aldrich and used as received. All other silyl ketene acetals were prepared from the commercially available 
methyl esters following the procedure reported by Wenzel and Jacobsen.2 
 
Abbreviations used: EtOAc – ethyl acetate, THF – tetrahydrofuran, MeOH – methanol, Et2O – diethyl ether, AcOH – acetic 
acid, TBME – t-butylmethyl ether, DIPEA – diisopropyl ethylamine, NaOMe – sodium methoxide, HBTU − O-benzotriazol-
1-yl-N,N,N’,N’-tetramethyluronium hexafluorophosphate, EDC – 1-(3- (dimethyl-amino)propyl)-3-ethyl-carbodiimide 
hydrochloride, HOBt – 1-Hydroxybenzotriazole, Boc – t-butyl carbamate, ee – enantiomeric excess.  
 
                                                 
1 Suffert, J. J. Org. Chem. 1989, 54, 509-510. 
2 Wenzel, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 12964-12965.  
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Step 1. Amide coupling: Method A. Preparation of tert-butyl (S)-1-((R)-2-(4-fluorophenyl)pyrrolidin-1-yl)-3,3-
dimethyl-1-oxobutan-2-ylcarbamate (S1): 
A flask was charged with (R)-tert-butyl 2-(4-fluorophenyl)pyrrolidine-1-carboxylate3 (0.85 g, 3.21 
mmol, 1.05 equiv) and HCl was added as a solution in dioxane  (4.0 N, 20.9 mmol, 5.2 mL, 6.8 
equiv). The reaction was stirred for 2 h at room temperature, then the flask was fitted with a vac-
transfer tube and receiving flask. The receiving flask was cooled to –78 °C and the HCl/dioxane were 
removed in vacuo. The solid residue was placed under vacuum for 30 min, then flushed with N2 and 
CH2Cl2 (6.0 mL) was added. A separate flask was charged with HBTU (1.15 g, 3.04 mmol, 1.0 equiv) and N-Boc-L-tert-
leucine (0.70 g, 3.04 mmol, 1.0 equiv), and CH2Cl2 (8.0 mL) was added. To the resulting suspension was added DIPEA (1.68 
mL, 9.63 mmol, 3.0 equiv), and after 10 min, the solution of the pyrrolidine salt (rinsed flask with 2 mL of CH2Cl2). After 30 
min the reaction was homogenous, and stirring was continued for 12 h before dilution with Et2O (20 mL). The cloudy 
mixture was washed once with 1N HCl (20 mL), once with saturated aqueous NaHCO3 (20 mL), once with brine, and the 
organic layer was dried over anhydrous Na2SO4. Following concentration under reduced pressure, the residue was purified by 
silica gel chromatography (gradient elution, 1:1:18 to 1:1:3 EtOAc:CH2Cl2:Hexanes) to give amide S1 (1.16 g, 92% yield) as 
a white foam. [α]D27 = +32° (c = 0.42 CHCl3); 1H NMR (400 MHz, CDCl3; compound exists as a 3.2:1 mixture of rotamers, 
the major rotamer is designated by *, minor rotamer denoted by §) δ 7.23 (dd, J=8.4, 5.2 Hz, 2H§), 6.97-7.05 (m, 2H*), 6.88 
(dd, J=8.8, 8.8 Hz, 2H*, 2H§), 5.35 (dd, J=8.4, 1.6 Hz, 1H§), 5.03-5.13 (m, 2H*, 1H§), 4.29 (d, J=10 Hz, 1H*), 4.15-4.20 (m, 
1H*), 4.06 (d, J=10.8 Hz, 1H§), 3.67 (m, 1H*, 2H§), 2.16-2.32 (m, 1H*, 1H§), 1.75-2.00 (m, 3H*, 3H§), 1.43 (s, 9H*), 1.41 
(s, 9H§), 1.00 (s, 9H*), 0.62 (s, 9H§). 13C NMR (100 MHz, CDCl3; compound exists as a 3.2:1 mixture of rotamers, the major 
rotamer is designated by *, minor rotamer denoted by §) δ 170.5*, 171.2§, 161.9§ (d, JC-F=244.2 Hz), 161.4* (d, JC-
F=242.7Hz), 156.2*, 155.6§, 139.9§ (d, JC-F=3.0 Hz), 138.4* (d JC-F=3.0 Hz), 128.2§ (d, JC-F=7.6 Hz), 126.6* (d, JC-F=8.3 Hz), 
115.3§ (d, JC-F=21.2 Hz), 115.0* (d, JC-F=21.2 Hz), 79.5*, 79.4§, 60.7§, 59.9*, 58.6*, 57.5§, 48.1*, 46.8§, 35.8§, 34.2*, 34.3§, 
34.1*, 28.2*, 28.2§, 26.3*, 26.0§, 23.1*, 21.7§; FTIR (NaCl, thin film) 3445, 2971, 2873, 1713, 1652, 1509, 1426, 1367, 
1232, 1170, 832, 732 cm-1. LRMS (ES+) m/z: 379.5 [M+H]+.   
Note: Although the above procedure indicates that amide intermediate S1 was purified by column chromatography, catalysts 
were routinely prepared with only a single chromatographic purification of the final thiourea.   
 
                                                 
3 Campos, K. R.; Klapars, A.; Waldman, J. H.; Dormer, P. G.; Chen, C. Y. J. Am. Chem. Soc. 2006, 128, 3538-3539. 
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Step 1. Amide Coupling, Method B. Preparation of tert-butyl (S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-
dimethylpropylcarbamate (S2). 
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 To a solution of N-benzylmethylamine (2.13 mL, 16.5 mmol, 1.1 equiv) in CH2Cl2 (150 mL) in a 500 mL round-
bottom flask was added DIPEA (3.92 mL, 22.5 mmol, 1.5 equiv), followed by HOBT (2.23 g, 16.5 mmol, 1.1 equiv), EDC 
(3.16 g, 16.5 mmol, 1.1 equiv), and N-Boc-L-tert-leucine (3.47g, 15.0 mmol, 1.0 equiv). The reaction was stirred at room 
temperature for 18 h, then diluted with 150 mL Et2O and washed once each with 1N HCl (150 mL), saturate aqueous 
NaHCO3 (150 mL) and brine (150 mL). The organics were dried over Na2SO4, filtered, and concentrated under reduced 
pressure to give 4.89g (97% yield) of amide S2 as a white foam. This material was used in the subsequent step without 
purification.  
 
Step 2. Boc-deprotection and thiourea formation. Preparation 1-(3,5-bis(trifluoromethyl)phenyl)-3-((S)-1-((R)-2-(4-
fluorophenyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)thiourea (15). 
To a flask containing amide S1 (1.16g, 3.0 mmol) was added HCl as a solution in dioxane  
(4.0 N, 19.7 mmol, 4.9 mL, 6.5 equiv). The reaction was stirred for 2 h at room 
temperature, after which time the flask was fitted with a vac-transfer tube and receiving 
flask. The receiving flask was cooled to –78 °C and the HCl/dioxane were removed in 
vacuo. The solid residue was placed under vacuum for 30 min, then flushed with N2 and 
CH2Cl2 (15.0 mL) was added. To the resulting solution was added Et3N (1.26 mL, 9.00 
mmol, 3.0 equiv), followed by 3,5-bis(trifluoromethyl)phenyl isothiocyanate (0.61 mL, 3.30 mmol, 1.1 equiv). The reaction 
was stirred for 4 h at room temperature, and then concentrated under reduced pressure. The residue was purified by silica gel 
chromatography (2:1 EtOAc:Hexanes) to give thiourea 15 (1.3 g, 79% yield) as a white solid. [α]D26 = –2.84° (c = 1.0 
CHCl3); 1H NMR (500 MHz, CDCl3; compound exists as a 2.2:1 mixture of rotamers, the major rotamer is denoted by *, 
minor rotamer denoted by §) δ 9.53 (br. s, 1H§), 9.47 (br.s, 1H*), 8.00 (s, 2H§), 7.86 (s, 2H*), 7.66 (s, 1H§), 7.62 (s, 1H*), 
7.52 (d, J=8.0 Hz, 1H*), 7.43 (d, J=10.0 Hz, 1H§), 7.31 (dd, J=9.0, JH-F=5.5 Hz, 2H§), 7.06 (dd, J=9.0, JH-F=9.0 Hz, 2H§), 
6.89 (dd, J=8.5, JH-F=5.5 Hz, 2H*), 6.66 (dd, J=8.5, JH-F=8.5 Hz, 2H*), 5.81 (d, J=7.5 Hz, 1H§), 5.49 (d, J=9.5 Hz, 1H*), 
5.30 (d, J=10.0 Hz, 1H§), 5.07 (d, J=7.5 Hz, 1H*), 4.42-4.48 (m, 1H*), 3.81 (dd, J=17.5, 9.0 Hz, 1H*), 3.54-3.57 (m, 2H§), 
2.19-2.32 (m, 1H*, 1H§), 2.02-2.14 (m, 1H§), 1.76-2.05 (m, 3H*, 2H§), 1.15 (s, 9H*), 0.71 (s, 9H§); 13C NMR (126 MHz, 
CDCl3; compound exists as a 2.2:1 mixture of rotamers, the major rotamer is designated by *, minor rotamer denoted by §) δ 
181.4*, 181.1§, 172.5§, 170.5*, 162.3§ (d, JC-F=244.8 Hz), 161.3* (d, JC-F=243.1 Hz), 140.2§, 139.7*, 139.2§ (d, JC-F=2.7 Hz), 
137.1* (d, JC-F=2.5 Hz), 132.1* (q, JC-F=33.7 Hz), 131.9§ (q, JC-F=33.6 Hz), 128.3§ (d, JC-F=7.2 Hz), 126.7* (d, JC-F=8.1Hz), 
123.9* (m), 123.7§ (m), 123.1§ (q, JC-F=271.2 Hz), 123.0* (q, JC-F=271.2 Hz), 118.6* (m), 118.3§ (m), 115.6§ (d, JC-F=21.0 
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Hz), 114.8* (d, JC-F=21.9 Hz), 63.1*, 61.7§, 61.6§, 60.6*, 48.6*, 47.6§, 35.9§, 35.6*, 35.3§, 34.2*, 26.9*, 26.8§, 23.0*, 21.5§; 
FTIR (NaCl, thin film) cm-1; LRMS (ES+) m/z: 550.6 [M+H]+. 
 
1-((S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-dimethylpropyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea (10).  
Prepared from 15.0 mmol of N-Boc-L-tert-leucine using amide coupling Method B, 
with a single silica gel chromatographic purification (gradient elution, 1:9 to 1:5 
EtOAc:Hexanes) of the final thiourea to give 6.71 g (89% yield over three steps) of 
10 as a white powder. [α]D26 = –52.0 ° (c = 1.00, CHCl3); 1H NMR (500 MHz, 
CDCl3; compound exists as a 4.4:1 mixture of rotamers: the major rotamer is denoted 
by *) δ 9.29 (1 H, br. s.), 9.01 (1 H*, br. s.), 7.96 (2 H, s), 7.93 (1 H + 1H*, br. m), 7.85 (2 H*, s), 7.59 (1 H, s), 7.56 (1 H*, 
s), 7.29 (I H* + 1 H, s), 7.16-7.22 (4 H* + 4 H, m), 5.98 (1 H, d, J=9.5 Hz), 5.70 (1 H*, d, J=9.0 Hz), 5.15 (1 H, d, J=15.0 
Hz), 4.97 (1 H*, d, J=14.5 Hz), 4.46 (1 H, d, J=15.0 Hz), 4.22 (1 H*, d, J=14.5 Hz), 3.26 (3 H*, s), 2.79 (3 H, s), 1.15 (9 H*, 
s), 1.14 (9 H, s); 13C NMR (126 MHz, CDCl3; compound exists as a 4.4:1 mixture of rotamers, only the major rotamer is 
reported) δ 182.0, 174.1, 140.3, 135.7, 131.8 (q, JC-F=33.8 Hz), 128.9, 128.3, 128.0, 124.4, 122.2, 118.5 (m), 61.4, 52.2, 36.8, 
36.4, 27.5; FTIR (NaCl, thin film) 3324 (br), 3091 (m), 3067 (m), 3035 (m), 2969 (s), 1614 (s), 1532 (s), 1474 (m), 1384 (s), 
1280 (s), 1179 (s), 1132 (s), 962 (m), 911 (m), 734 (m), 700 (m), 682 (m) cm-1; HRMS (ES+) [M+Na]+ calculated for 
C23H24F6NaN3OS: 505.1622, Found 528.1512. 
 
1-((S)-1-(N-methyl-N-((S)-1-phenylethyl)carbamoyl)-2,2-dimethylpropyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea 
(11). Prepared from 2.0 mmol of N-Boc-L-tert-leucine using amide coupling Method 
B, with a single silica gel chromatographic purification (gradient elution, 1:9 to 1:5 
EtOAc:Hexanes) of the final thiourea to give 0.65 g (63% yield over three steps) of 11 
as a white powder. [α]D 26 = –77.8° (c = 1.03 CHCl3); 1H NMR (400 MHz, CDCl3; 
compound exists as a 7.5:1 mixture of rotamers, the major rotamer is denoted by *) δ 9.27 (1 H, s), 8.97 (1 H*, s), 7.97 (2 H, 
s), 7.93 (2 H*, s), 7.76 (1 H*, d, J=9.1 Hz), 7.65 (1 H, s), 7.64 (1 H*, s), 7.23 - 7.44 (5 H + 5 H*, m), 6.12 (1 H, d, J=10.2 
Hz), 5.97 (1 H*, q, J=7.0 Hz), 5.59 (1 H*, d, J=9.1 Hz), 2.94 (3 H*, s), 2.60 (3 H, s), 1.70 (3 H, d, J=6.6 Hz), 1.36 (3 H*, d, 
J=7.0 Hz), 1.19 (9 H, s), 1.12 (9 H*, s); 13C NMR (CDCl3, 126 Mhz; compound exists as a 7.5:1 mixture of rotamers, the 
major rotamer is denoted by *) δ 181.8*, 181.2, 173.0*, 172.1, 140.2, 140.1*, 139.6*, 138.8, 132.2* (q, JC-F=42.0 Hz), 
128.9*, 128.8, 128.2, 128.0*, 127.7*, 127.5, 124.6* (q, JC-F= 3.8 Hz), 121.9*, 118.9*, 61.9*, 60.7, 55.7, 52.3*, 36.7*, 31.2*, 
28.4, 27.5*, 17.1, 15.1*; FTIR (NaCl, thin film) cm-1  3321 (br), 3091 (w), 2066 (w), 3034 (w), 2971 (m), 1604 (s), 1532 (s), 
1473 (s), 1383 (s), 1278 (s), 1178 (s), 1136 (s), 962 (m), 910 (m), 888 (m), 735 (m), 701 (m), 682 (m); HRMS (ES+) [M+H]+ 
calculated for C24H28F6N3OS: 520.1852, Found: 520.1861.  
 
1-((S)-1-(N-methyl-N-((R)-1-phenylethyl)carbamoyl)-2,2-dimethylpropyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea 
(12). Prepared from 2.0 mmol of N-Boc-L-tert-leucine using amide coupling Method B, with a single silica gel 
chromatographic purification (gradient elution, 1:9 to 1:5 EtOAc:Hexanes) of the final thiourea to give 0.65 g (51% yield 
over three steps) of 12 as a white powder. [α]D26 = +79.0° (c = 1.05 CHCl3); 1H NMR (CDCl3, 500 MHz; compound exists as 
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a 6:1 mixture of rotamers, the major rotamer is designated by *, minor rotamer 
denoted by §) δ 9.33 (br. s, 1 H§), 9.05 (br. s, 1 H*), 7.97 (d, J=9.2 Hz, 1 H*), 7.86 (s, 
2 H§), 7.79 (s, 2 H*), 7.55 (s, 1 H*, 1H§), 7.36 - 7.42 (m, 2 H§), 7.30 - 7.35 (m, 2 H§), 
7.00 - 7.11 (m, 5 H*), 5.93 (q, J=7.1 Hz, 1 H*, 1H§), 5.68 (d, J=9.4 Hz, 1 H*, 1H§), 
3.05 (s, 3 H*), 2.68 (s, 3 H§), 1.71 (d, J=6.9 Hz, 3 H§), 1.53 (d, J=7.1 Hz, 3 H*), 1.19 (s, 9 H*), 1.13 (s, 9 H§); 13C NMR 
(CDCl3, 126 MHz; compound exists as a 6:1 mixture of rotamers, only the major rotamer is reported) δ 181.9, 173.2, 139.8, 
138.7, 131.8 (q, JC-F=33.0 Hz,), 128.4, 127.3, 126.6, 124.9, 122.9 (q, JC-F=272.8 Hz), 118.7, 61.5, 60.0, 36.4, 31.3, 27.2, 16.7; 
FTIR (NaCl, thin film) 3317, 2972, 1607, 1534, 1384, 1279, 1178, 1137, 962, 699, 682 cm-1; LRMS (ES+) m/z = 542.2 
[M+Na]+. 
 
1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-3,3-dimethyl-1-oxo-1-((R)-2-phenylpyrrolidin-1-yl)butan-2-yl)thiourea (13). 
Prepared from 2.85 mmol of N-Boc-D-tert-leucine using amide coupling Method A. 
Amide coupling product was purified by silica gel chromatography (1:4 EtOAc:Hexanes) 
to give 0.97 g (95% yield) as a white foam. Thiourea 13 was purified by silica gel 
chromatographic purification (gradient elution, 1:4 EtOAc:Hexanes) to give 1.25 g (82% 
yield over three steps) as a white foam. [α]D = 130.1° (c = 0.7, CHCl3); 1H NMR (CDCl3, 
399 MHz; compound exists as a 10:1 mixture of rotamers, chemical shifts of the major rotamer are reported) δ 9.01 (br. s, 1 
H), 7.91 (s, 2 H), 7.79 (d, J=9.2 Hz, 1 H), 7.59 (s, 1 H), 7.24 (d, J=7.3 Hz, 2 H), 7.20 (d, J=7.0 Hz, 1 H), 7.12 (d, J=7.0 Hz, 2 
H), 5.37 (d, J=8.8 Hz, 1 H), 4.94 (dd, J=7.0 Hz, 1 H), 4.39 - 4.48 (m, 1 H), 3.82 (ddd, J=10.3, 7.0 Hz, 1 H), 2.19 - 2.30 (m, 1 
H), 2.05 - 2.15 (m, 1 H), 1.83 - 2.04 (m, 2 H), 0.99 (s, 9 H); 13C NMR (CDCl3, 126 MHz; compound exists as a 10:1 mixture 
of rotamers, the chemical shifts of the major rotamer are reported) δ 181.8, 172.2, 142.3, 140.2, 131.6 (q, JC-F=33.9 Hz), 
128.3, 127.0, 126.1, 123.5-124.0 (m), 123.0 (q, JC-F=272.8 Hz), 117.9 - 118.6 (m), 63.5, 62.6, 49.8, 35.8, 34.0,  27.2, 24.8; 
FTIR (NaCl, thin film) 3318, 2970, 1611, 1539, 1473, 1440, 1385, 1278, 1178, 1134, 963, 699, 681 cm-1; LRMS (ES+) m/z = 
554.1 [M+23]+.  
 
1-(3,5-bis(trifluoromethyl)phenyl)-3-((S)-3,3-dimethyl-1-oxo-1-((R)-2-phenylpyrrolidin-1-yl)butan-2-yl)thiourea (14). 
Prepared from 1.46 mmol of N-Boc-L-tert-leucine using amide coupling Method A, with 
a single silica gel chromatographic purification (gradient elution, 1:9 to 1:3 
EtOAc:Hexanes) of the final thiourea to give 0.32 g (42% yield over three steps) of 14 as 
a white powder. [α]26D = –3.30° (c = 1.0, CHCl3); 1H NMR (500 MHz, CDCl3; compound 
exists as a 1.8:1 mixture of rotamers, the major rotamer is designated by *, minor rotamer 
denoted by §) δ 9.40 (br. s, 1 H§), 9.23 (br. s, 1 H*), 7.98 (s, 2 H§), 7.85 (s, 2 H*), 7.66 (s, 1 H§), 7.62 (s, 1 H*), 7.49 (d, J=8.7 
Hz, 1 H*), 7.24-7.37 (m, 6 H§), 6.97-6.99 (m, 3 H*), 6.88 (dd, J=7.5, 2.5 Hz, 2 H*), 5.78 (d, J=7.8 Hz, 1 H§), 5.57 (d, J=9.6 
Hz, 1 H*), 5.32 (d, J=8.2 Hz, 1 H§), 5.09 (d, J=7.8 Hz, 1 H*), 4.34 - 4.50 (m, 1 H*), 3.82 (dd, J=18.3, 10.1 Hz, 1 H*), 3.52 - 
3.65 (m, 2 H§), 2.28 - 2.39 (m, 1 H§), 2.16 - 2.28 (m, 1 H*), 2.06 - 2.16 (m, 1 H§), 1.75 - 1.99 (m, 3 H* + 2 H§), 1.15 (s, 9 
H*), 0.66 (s, 9 H§); 13C NMR (126 MHz, CDCl3; compound exists as a 1.8:1 mixture of rotamers, the major rotamer is 
designated by *, minor rotamer denoted by §) δ 181.9*, 181.4§, 172.7§, 170.9*, 143.5§, 141.4*, 140.6§, 140.2*, 132.1* (q, JC-
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F=33.9 Hz), 132.0§ (q, JC-F=33.8 Hz), 129.0§, 128.3*, 128.0§, 126.9*, 126.8§, 125.2*, 124.4*, 124.1§, 122.3§, 122.2*, 118.7* 
(m), 118.5§ (m), 63.1*, 62.6§, 61.8§, 61.3*, 49.0*, 47.9§, 36.2§, 36.0*, 35.5§, 34.3*, 27.2*, 27.0§, 23.2*, 21.8§; FTIR (NaCl, 
thin film) cm-1  3325 (br), 2966 (m), 2875 (m), 1614 (s), 1528 (s), 1474 (m), 1449 (m), 1385 (S), 1278 (s), 1177 (s), 1134 (s), 
962 (m), 910 (m) 886 (m), 734 (m), 700 (m), 682 (m); HRMS (ES+) [M+H]+ calculated for C25H28F6N3OS: 532.1857, Found: 
532.1871.  
 
1-(3,5-bis(trifluoromethyl)phenyl)-3-((R)-3,3-dimethyl-1-oxo-1-(pyrrolidin-1-yl)butan-2-yl)thiourea (16). Prepared from 
1.0 mmol of N-Boc-L-tert-leucine using amide coupling Method B, with a single silica gel 
chromatographic purification (gradient elution, 1:9 to 1:3 EtOAc:Hexanes) of the final 
thiourea to give 0.28 g (61% yield over three steps) of 14 as a white powder. [α]26D = –
19.2° (c = 1.0, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 9.52 (br. s, 1 H), 7.96 (s, 2 H), 7.92 
(d, J=9.3 Hz, 1 H), 7.60 (s, 1 H), 5.56 (d, J=9.3 Hz, 1 H), 4.16 (ddd, J=10.7, 7.3, 4.4 Hz, 1 H), 3.62 (ddd, J=10.1, 7.6 Hz, 1 
H), 3.44 (ddd, J=12.0, 7.1, 5.4 Hz, 1 H), 3.26 (ddd, J=12.2, 7.8 Hz, 1 H), 1.87 - 2.04 (m, 2 H), 1.78 - 1.86 (m, 2 H), 1.15 (s, 9 
H); 13C NMR (CDCl3, 100 MHz) δ 182.3, 171.8, 140.5, 131.4 (q, JC-F=33.7 Hz), 124.56 - 125.0 (m), 123.1 (d, J=272.3 Hz), 
118.0 - 118.4 (m), 62.8, 48.5, 46.7, 36.0, 27.1, 25.8, 24.0; FTIR (NaCl, thin film) 3317, 2969, 2882, 1609, 1534, 1453, 1384, 
1278, 1177, 1133, 936, 731 cm-1; LRMS (ES+) m/z = 478.1 [M+Na]+. 
 
C. General procedure for thiourea-catalyzed addition of silyl ketene acetals to 1-chloroisochromans. 
Method A (catalyst screening). 
 An oven-dried flask was charged with thiourea catalyst (0.015 mmol, 0.1 equiv), flushed with N2, and TBME (1.3 
mL) was added. The flask was cooled to –78 °C and the 1-chloroisochroman was added (0.20 mL of a 0.75 M stock solution 
in TBME, 0.15 mmol, 1.0 equiv), followed by the silyl ketene acetal (0.22 mmol, 1.5 equiv). The reaction was maintained at 
–78 °C for a given amount of time, then quenched at that temperature by addition of NaOMe (0.1 mL of 0.5 M solution in 
MeOH). The reaction was diluted with 1 mL of 50% Et2O-Hexanes soution, filtered through a pipette containing ¾ inch of 
silica gel (to hydrolyze remaining silyl ketene acetal), and rinsed with 5 mL of the 50% Et2O-Hexanes solution. The solvent 
was removed by rotary evaporation under reduced pressure to give the crude residue, which was purified by silica gel 
chromatography. 
 To facilitate determination of conversion by 1H NMR analysis of the crude reaction mixtures, the 1-
chloroisochroman stock solution contained 0.25 equiv of isochroman as an internal standard. Upon reaction quenching, any 
remaining 1-choroisochroman is converted quantitatively to the 1-methoxyisochroman. Thus, integration of the C1-proton of 
the 1-methoxyisochroman versus the C1 protons of isochroman correlates to unreacted starting material. 
 
Method B.  
 In an oven-dried flask, 1-methoxyisochroman (6, 0.30 mmol, 1.0 equiv) was dried by azeotrope with benzene (2 x 2 
mL), flushed with N2, and dry CH2Cl2 (0.4 mL) was added. The solution was cooled to 0 °C and BCl3 (1.0 M solution in 
hexanes, 0.10 mL, 0.35 equiv) was added dropwise. The reaction was warmed to room temperature and stirred for 1.5 h, after 
which time the solvent was removed in vacuo. The crude residue was placed under vacuum (1 torr) for 30 min, then flushed 
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with N2 and dissolved in dry TBME (2.0 mL). The resulting solution was cooled to –78 °C and the thiourea catalyst was 
added as a solution in TBME (0.03 mmol, 1.0 mL of 0.03 M stock solution, 0.10 equiv), followed by the silyl ketene acetal 
(0.45 mmol, 1.5 equiv). After the given amount of time, the reaction was quenched by addition of NaOMe (0.2 mL of 0.5 M 
solution in MeOH). The reaction was diluted with 2 mL of 50% Et2O-Hexanes solution, filtered through a 10 mL fritted 
funnel containing silica gel (to hydrolyze remaining silyl ketene acetal), and rinsed with 15 mL of the 50% Et2O-Hexanes 
solution. The solvent was removed by rotary evaporation under reduced pressure to give the crude residue, which was 
purified by silica gel chromatography.  
 
Isopropyl 2-(3,4-dihydro-1H-isochromen-1-yl)acetate (9a). Catalyst screen using catalysts 10-16 (see Table 1). All 
reactions were run for 6 h at –78 °C. Purified by silica gel chromatography (pipette column, 1:9 
Et2O:Hexanes). The enantiomeric excess was determined by chiral HPLC analysis (S, S-Whelk-01, 1 
mL/min, 2% IPA in Hexanes, λ = 210 nm): tR(major) = 12.0 min tR(minor) = 10.8 min. 1H NMR (CDCl3, 
500 MHz) δ 7.15 - 7.21 (m, 2 H), 7.09 - 7.15 (m, 1 H), 7.05 (dd, J=5.5, 3.7 Hz, 1 H), 5.24 (dd, J=9.2, 3.7 Hz, 1 H), 5.10 (dt, 
J=12.7, 6.2 Hz, 1 H), 4.13 (ddd, J=11.4, 4.8 Hz, 1 H), 3.82 (ddd, J=11.8, 8.6, 3.9 Hz, 1 H), 2.97 (ddd, J=15.7, 9.5, 5.5 Hz, 1 
H), 2.82 - 2.89 (dd, J=15.0, 3.5 Hz, 1 H), 2.71 - 2.77 (dd, J=15.0, 9.5 Hz, 1 H), 2.73 (dd, J=16.0, 8.2 Hz, 1 H), 1.26 (d, J=6.5 
Hz, 3H), 1.25 (d, J=6.0 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 170.7, 136.9, 133.9, 129.0, 126.6, 126.2, 124.5, 72.9, 67.9, 
63.0, 42.0, 28.8, 21.8, 21.7; FTIR (NaCl, thin film) 2979, 2932, 2855, 1732, 1454, 1374, 1282, 1167, 1105, 749 cm-1; LRMS 
(ES+) m/z = 257.1 [M+Na]+. 
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Figure S1. Enantioselectivities of additional catalysts screened using Method A (0.050 mmol scale) and silyl ketene acetal 9a, –78 °C.
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Methyl 2-((S)-3,4-dihydro-1H-isochromen-1-yl)acetate (9b). Method B: The reaction was run on 0.33 mmol scale for 6 h. 
The crude material was purified by silica gel chromatography (1:9 Et2O:Hexanes) to give 59 mg (87% 
yield) of 9b as a colorless oil. The enantiomeric excess was determined to be 85% by chiral HPLC 
analysis (S, S-Whelk-01, 1 mL/min, 2% IPA in Hexanes, λ = 210 nm): tR(major) = 15.1 min tR(minor) = 
13.9 min. [α]D26 = –93.9° (c = 0.77, CHCl3); 1H NMR (CDCl3, l00 MHz) δ 7.19 (ddd, J=8.9, 3.4, 3.4 
Hz, 2H) 7.13 (dd, J=5.7, 4.1 Hz, 1 H), 7.05 (dd, J=5.3, 3.7 Hz, 1 H), 5.26 (dd, J=9.6, 3.2 Hz, 1 H), 4.14 (ddd, J=11.4, 4.7 Hz, 
1 H), 3.83 (ddd, J=11.3, 9.0, 3.9 Hz, 1 H), 3.76 (s, 3 H), 2.99 (ddd, J=15.6, 8.9, 5.3 Hz, 1 H), 2.91 (dd, J=15.1, 3.4 Hz, 1 H), 
2.78 (dd, J=15.3, 9.8 Hz, 1 H), 2.73 (ddd, J=16.3, 3.9 Hz, 1 H); 13C NMR (CDCl3, 126 MHz) δ 171.7, 136.6, 133.9, 129.0, 
126.7, 126.2, 124.4, 72.9, 63.1, 51.8, 41.5, 28.8; FTIR (NaCl, thin film) 2952, 2925, 2857, 1743, 1506, 1435, 1284, 1167, 
1111 cm-1; LRMS (ES+) m/z = 229.1 [M+Na]+. 
 
Methyl 2-((S)-3,4-dihydro-5-methyl-1H-isochromen-1-yl)acetate (9c). Method B: The reaction was run on 0.3 mmol 
scale for 7.5 h. The crude material was purified by silica gel chromatography (1:9 Et2O:Hexanes) to give 
47 mg (71% yield) of 9c as a colorless oil. The enantiomeric excess was determined to be 90% by chiral 
HPLC analysis (S,S-Whelk-01, 1 mL/min, 2% IPA in Hexanes, λ = 210 nm): tR(major) = 15.9 min, 
tR(minor) = 14.9 min. [α]D27 = –91.2° (c = 0.605, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.11 (dd, J=7.5, 
7.5 Hz, 1 H), 7.06 (d,  J=7.0 Hz, 1 H), 6.91 (d,  J=7.5 Hz, 1 H), 5.25 (dd, J=10.0, 3.0 Hz, 1 H), 4.16 (ddd,  J=11.5, 5.5, 4.0 
Hz, 1 H), 3.84 (ddd, J=11.5, 9.0, 4.5 Hz, 1 H), 3.76 (s, 3 H), 2.89 (dd, J=15.0, 3.5 Hz, 1 H), 2.77 (dd,  J=15.0, 9.5 Hz, 1 H), 
2.74-2.83 (m, 1 H), 2.62 (ddd, J=16.5, 4.5, 4.5 Hz, 1 H), 2.24 (s, 3 H); 13C NMR (CDCl3, 126 MHz) δ 171.8, 136.4, 135.8, 
130.8, 128.9, 127.6, 125.0, 72.9, 63.2, 51.8, 41.6, 28.4, 21.1; FTIR (NaCl, thin film) 2952, 2924, 2857, 1743, 1469, 1436, 
1367, 1276, 1158, 1116, 1030, 785, 758 cm-1 LRMS (ES+) m/z = 243.1 [M+Na]+.  
 
Methyl 2-((S)-3,4-dihydro-6-methyl-1H-isochromen-1-yl)acetate (9d). Method B: The reaction was run on 0.30 mmol 
scale for 7.5 h. The crude material was purified by silica gel chromatography (1:9 Et2O:Hexanes) to 
give 53 mg (82% yield) of 9d as a colorless oil. The enantiomeric excess was determined to be 84% 
by chiral HPLC analysis (CHIRALPAK AS-H, 1 mL/min, 2% EtOH in Hexanes, λ = 210 nm): 
tR(major) = 8.5 min, tR(minor) = 7.1 min. [α]D27 = –97.1° (c = 0.735, CHCl3); 1H NMR (CDCl3, 500 
MHz) δ 7.00 (d, J=8.5 Hz, 1 H), 6.94 (s, 1 H), 6.94 (d, J=8.0 Hz, 1 H), 5.22 (dd,  J=10.0, 2.5 Hz, 1 H), 4.12 (ddd, J=11.5, 
4.5, 4.5 Hz, 1 H), 3.80 (ddd, J=11.5, 9.5, 3.5 Hz, 1 H), 3.75 (s, 3 H), 2.95 (ddd,  J=15.5, 9.5, 5.5 Hz, 1 H), 2.88 (dd,  J=15.5, 
3.5 Hz, 1 H), 2.74 (dd, J=15.0, 10.0 Hz, 1 H), 2.68 (ddd, J=16.0, 4.0, 4.0 Hz, 1 H), 2.31 (s, 3 H); 13C NMR (CDCl3, 126 
MHz) δ 171.8, 136.3, 133.7, 133.6, 129.6, 127.1, 124.3, 72.9, 63.2, 51.8, 41.6, 28.8, 20.9; FTIR (NaCl, thin film) 2950, 2926, 
2855, 1742, 1435, 1372, 1284, 1182, 1108, 1051, 822 cm-1; LRMS (ES+) m/z = 243.1 [M+Na]+. 
 
Methyl 2-((S)-3,4-dihydro-7-methyl-1H-isochromen-1-yl)acetate (9e). Method B: The reaction was run on 0.30 mmol 
scale for 7.5 h. The crude material was purified by silica gel chromatography (1:9 Et2O:Hexanes) to give 54 mg (82% yield) 
of 9e as a colorless oil. The enantiomeric excess was determined to be 87% by chiral HPLC analysis (S,S-Whelk-01, 1 
mL/min, 2% IPA in Hexanes, λ = 210 nm): tR(major) = 13.3 min, tR(minor) = 12.6 min. [α]D27 = 91.9° (c = 0.77, CHCl3); 1H 
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NMR (CDCl3, 500 MHz) δ 7.02 (d, J=7.5 Hz, 1 H), 7.00 (d, J=8.0 Hz, 1 H), 6.85 (s, 1 H), 5.22 (dd, 
J= 9.5, 2.5 Hz, 1H), 4.11 (ddd, J=11.5, 5.0, 5.0 Hz, 1 H), 3.79 (ddd, J=11.5, 9.0, 3.5 Hz, 1 H), 3.76 (s, 
3 H), 2.93 (ddd, J=16.0, 12.5, 6.0 Hz, 1 H), 2.89 (dd, J=15.0, 3.5 Hz, 1 H), 2.76 (dd, J=15.0, 10.0 Hz, 
1 H), 2.68 (ddd, J=17.0, 4.0, 4.0 Hz, 1 H), 2.31 (s, 3 H); 13C NMR (CDCl3, 126 MHz) δ 171.7, 136.4, 
135.7, 130.8, 128.9, 127.5, 124.9, 72.9, 63.1, 51.8, 41.6, 28.4, 21.1; FTIR (NaCl, thin film): 3022, 2952, 2854, 1742, 1436, 
1283, 1197, 1164, 1109, 750 cm-1; LRMS (ES+) m/z = 243.1 [M+Na]+. 
 
Methyl 2-((S)-6-fluoro-3,4-dihydro-1H-isochromen-1-yl)acetate (9f). Method B: The reaction was run on 0.30 mmol 
scale for 21 h. The crude material was purified by silica gel chromatography (1:4 Et2O:Hexanes) to give 
47 mg (70% yield) of 9f as a colorless oil. The enantiomeric excess was determined to be 90% by chiral 
HPLC analysis (S,S-Whelk-01, 1 mL/min, 2% IPA in Hexanes, λ = 210 nm): tR(major) = 16.4 min, 
tR(minor) = 15.1 min. [α]D27 = –107.1° (c = 0.83, CHCl3); 1H NMR (CDCl3, 600 MHz) δ 7.00 (dd, 
J=8.4, 6.0 Hz, 1 H), 6.87 (ddd, J=8.4, 8.4, 2.4 Hz, 1 H), 6.82 (dd, J=9.0, 3.0 Hz, 1 H), 5.19 (dd, J=8.4, 2.4 Hz, 1 H), 4.14 
(ddd, J=10.8, 4.8, 4.8 Hz, 1 H), 3.78 (ddd, J=11.4, 9.0, 3.6 Hz, 1 H), 3.74 (s, 3 H), 2.96 (ddd, J=15.6, 9.0, 6.0 Hz, 1 H), 2.85 
(dd, J=15.6, 3.6 Hz, 1 H), 2.74 (dd, J=15.6, 8.0 Hz, 1 H), 2.69 (ddd, J=16.2, 4.2, 4.2 Hz, 1 H); 13C NMR (CDCl3, 126 MHz) 
δ 171.5, 161.3, 136.2, 132.3, 126.1, 115.3, 113.4, 72.6, 62.8, 51.9, 41.5, 28.9; FTIR (NaCl, thin film) 2954, 2857, 1742, 
1500, 1437, 1285, 1236, 1164, 1106 cm-1; LRMS (ES+) m/z = 247.1 [M+23]+.  
 
Methyl 2-((S)-3,4-dihydro-6-methoxy-1H-isochromen-1-yl)acetate (9g). Method B: The reaction was run on 0.30 mmol 
scale for 22 h. The crude material was purified by silica gel chromatography (1:5 EtOAc:Hexanes) 
to give 68 mg (96% yield) of 9g as a colorless oil. The enantiomeric excess was determined to be 
74% by chiral HPLC analysis (CHIRALPAK AD-H, 1 mL/min, 5% IPA in Hexanes, λ = 210 nm): 
tR(major) = 11.1 min, tR(minor) = 10.6 min. [α]D27 = –77.2° (c = 0.67, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 6.96 (d, J=8.5 
Hz, 1 H), 6.75 (dd, J=8.6, 2.6 Hz, 1 H), 6.66 (d, J=2.3 Hz, 1 H), 5.20 (dd, J=9.6, 3.2 Hz, 1 H), 4.11 (ddd, J=11.3, 4.8 Hz, 1 
H), 3.76 - 3.84 (m, 4 H), 3.75 (s, 3 H), 2.96 (ddd, J=15.6, 9.2, 5.3 Hz, 1 H), 2.86 (dd, J=15.1, 3.4 Hz, 1 H), 2.74 (dd, J=15.1, 
9.6 Hz, 1 H), 2.69 (ddd, J=16.3, 4.1 Hz, 1 H); 13C NMR (CDCl3, 126 MHz) δ 171.7, 158.1, 135.2, 128.8, 125.5, 113.5, 112.5, 
72.7, 63.0, 55.2, 51.8, 41.6, 29.1; FTIR (NaCl, thin film) 2953, 2930, 2849, 1740, 1611, 1504, 1435, 1285, 1243, 1164, 1108, 
1036 cm-1, LRMS (ES+) m/z = 259.1 [M+Na]+. 
 
Methyl 2-(3,4-dihydro-1H-isochromen-1-yl)-2-methylpropanoate (18a). Method B: The reaction was run on 0.30 mmol 
scale for 24 h. The crude material was purified by silica gel chromatography (1:9 Et2O:Hexanes) to give 
65 mg (92% yield) of 18a as a colorless oil. The enantiomeric excess was determined to be 92% by chiral 
GC analysis (β-cyclodex, 105° C isothermal, 7 psi): tR(major)=  190.5 min, tR(minor)=192.8 min. [α]D26 = 
–113.6° (c = 1.1, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.16 (m, 2H), 7.11 (d, J=8.5 Hz, 1H), 6.97 (d, 
J=7.5 Hz, 1H), 5.17 (s, 1H), 4.14 (ddd, J=10.5, 5.0, 2.0 Hz, 1H), 3.76 (s, 3H), 3.78 (ddd, J=11.5, 10.5, 2.5 
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Hz, 1H), 2.99 (ddd, J=16.0, 11.5, 5.0 Hz, 1H), 2.53 (d, J=15.5 Hz, 1H), 1.13 (s, 3H), 1.11 (s, 3H); 13C NMR (CDCl3, 126 
MHz) δ 177.6, 135.4, 134.8, 128.7, 126.4, 125.8, 125.7, 80.1, 64.0, 51.9, 49.0, 30.1, 21.1, 20.9; IR (NaCl, thin film) 2980, 
2948, 2858, 1738, 1467, 1267, 1190, 1132, 1105, 748 cm-1. LRMS (ES+) m/z = 257.1 [M+Na]+.  
5.0 mmol scale: A flame-dried 100 mL flask was charged with 1-methoxyisochroman (6, 0.84 g, 5.00 mmol, 1.0 equiv), 
flushed with N2, and dry CH2Cl2 (4.0 mL) was added. The solution was cooled to 0 °C and BCl3 (1.0 M in hexanes, 2.00 mL, 
2.00 mmol, 0.4 equiv) was added dropwise over 5 min. The reaction was stirred for 5 min at 0 °C then 1.5 h at room 
temperature, after which time the flask was quickly fitted with an oven-dried vac-transfer tube and receiving flask under N2. 
The receiving flask was cooled to –78 °C, and the solvent was removed in vacuo (1 torr). Once the solvent was removed, the 
vac-transfer tube was disconnected and the flask was placed under vacuum for an additional 30 min, then back-filled with N2. 
The flask was fitted with a septum and TBME (40 mL) was added. The solution was cooled to –78 °C and thiourea 15 (137 
mg, 0.25 mmol, 0.05 equiv) was added as a solution in TBME (8 mL, plus 2 mL wash). After 5 min, silyl ketene acetal 17a 
(1.23 mL, 6.25 mmol, 1.25 equiv) was added dropwise and the flask was packed in dry ice in an insulated container for 22 h, 
then quenched at –78 °C with NaOMe (0.5 M solution in MeOH, 3.3 mL). The heterogeneous mixture was warmed to room 
temperature, diluted with 30 mL 1:1 Et2O:Hexanes, filtered through a 60 mL fritted funnel containing 1 cm silica gel, and 
rinsed with 40 mL (total) 1:1 Et2O/Hexanes. The solvent was removed by rotary evaporation under reduced pressure and the 
crude residue was purified by silica gel chromatography (1:9 Et2O:Hexanes) to give 18a (1.11g, 95% yield) as a colorless oil. 
The enantiomeric excess was determined to be 91% by chiral GC analysis (see above for conditions). 
 
Methyl 1-(3,4-dihydro-1H-isochromen-1-yl)cyclohexanecarboxylate (18b). Method B: The reaction was run on 0.3 mmol 
scale for 24 h. The crude material was purified by silica gel chromatography (1:9 Et2O:Hexanes) to give 69 
mg (84% yield) of 18b as a white solid. The enantiomeric excess was determined to be 94% by chiral 
HPLC analysis (Chiralcel OD-H, 0.5 mL/min, 1% IPA in Hexanes, λ = 210 nm): tR(major) = 14.7 min, 
tR(minor) = 11.1 min. [α]D26 = –184.9° (c = 0.73, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.14 - 7.19 (m, 
2H), 7.10 (dd, J = 8.5, 2.5 Hz, 1H), 6.97 (dd, J = 8.5, 1.5 Hz, 1H), 4.97 (s, 1H), 4.14 (ddd, J = 10.5, 5.0, 1.5 Hz, 1H), 3.72 (s, 
3H), 3.52 (ddd, J = 11.0, 11.0, 2.5 Hz, 1H), 2.95 (ddd, J = 16.0, 11.5, 4.5 Hz, 1H), 2.51 (d, J = 15.5 Hz, 1H), 2.13 (d, J = 13.0 
Hz, 1H), 1.90 (d, J = 12.5 Hz, 1H), 1.59 (m, 3H), 1.42 (ddd, J = 13.0, 13.0, 3.0 Hz, 1H), 1.23 - 1.36 (m, 3H), 1.02 - 1.08 (m, 
1H); 13C NMR (CDCl3, 126 MHz) δ 175.8, 136.8, 134.1, 128.4, 126.6, 126.5, 125.5, 81.1, 63.8, 54.9, 51.5, 30.4, 29.6, 29.4, 
25.7, 23.2, 23.1; FTIR (NaCl, thin film) 2935, 2855, 1736, 1453, 1215, 1131, 1103, 748 cm-1; LRMS (ES+) m/z = 297.1 
[M+Na]+. 
 
Methyl 1-((R)-3,4-dihydro-1H-isochromen-1-yl)cyclopentanecarboxylate (18c). Method B: The reaction was run on 0.31 
mmol scale for 24 h. The crude material was purified by silica gel chromatography (1:9 Et2O:Hexanes) to 
give 66 mg (85% yield) of 18c as a colorless oil. The enantiomeric excess was determined to be 92% by 
chiral HPLC analysis (CHIRALPAK AD-H, 1.0 mL/min, 2% IPA in Hexanes, λ = 210 nm): tR(major) = 
5.2 min, tR(minor) = 6.1 min. [α]D26 = 111.8° (c = 0.85, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.09-7.17 
(m, 3H), 6.96 (d, J = 7.0 Hz, 1H), 5.23 (s, 1H), 4.17 (ddd, J = 11.0, 5.5, 2.5 Hz, 1H), 3.72 (s, 3H), 3.67 (ddd, J = 11.0, 11.0, 
3.0 Hz, 1H), 3.00 (ddd, J = 16.5, 11.0, 5.5 Hz, 1H), 2.59 (d, J = 16.0 Hz, 1H), 1.97-2.05 (m, 3H), 1.55-1.63 (m, 5H); 13C 
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NMR (CDCl3, 126 MHz) δ 171.7, 136.3, 136.0, 129.0, 126.6, 126.1, 125.5, 79.5, 64.4, 60.2, 52.2, 34.8, 31.9, 30.0, 26.0, 
25.8; IR (NaCl, thin film) 2951, 2869, 1733, 1452, 1267, 1232, 1192, 1162, 1108, 743 cm-1; LRMS (ES+) m/z = 283.1 
[M+Na]+. 
 
Methyl tetrahydro-4-((R)-3,4-dihydro-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18d). Method B: The reaction 
was run on 0.30 mmol scale for 24 h. The crude material was purified by silica gel chromatography (1:9 
EtOAc:Hexanes) to give 89 mg (87% yield) of 18d as a white solid. The enantiomeric excess was 
determined to be 93% by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 5% IPA in Hexanes, λ = 
210 nm): tR(major) = 7.9 min, tR(minor) = 7.3 min. [α]D26 = –97.6° (c = 0.98, CHCl3); 1H NMR (CDCl3, 
500 MHz) δ 7.15-7.23 (m, 2 H), 7.12 (d, J=7.8 Hz, 1 H), 6.97 (d, J=6.8 Hz, 1 H), 5.00 (s, 1 H), 4.15 (ddd, J=10.6, 5.0, 2.0 
Hz, 1 H), 3.83 (dd, J=12.0, 3.5 Hz, 2 H) 3.75 (s, 3 H), 3.53 (ddd, J=11.7, 2.0 Hz, 1 H), 3.38 – 3.45 (m, 2H), 2.93 (ddd, 
J=15.9, 11.5, 4.9 Hz, 1 H), 2.54 (d, J=15.6 Hz, 1 H), 2.02 (dd, J=13.4, 1.2 Hz, 1 H), 1.83 (dd, J=8.8, 3.9 Hz, 2 H), 1.74 (ddd, 
J=12.9, 4.9 Hz, 1 H); 13C NMR (CDCl3, 126 MHz) δ 174.9, 136.7, 133.2, 128.5, 126.7, 126.4, 125.7, 80.4, 65.3, 65.2, 63.7, 
52.5, 51.8, 30.2, 29.7, 29.5; FTIR (thin film) 2956, 2857, 1730, 1446, 1301, 1220, 1198, 1135, 1101, 1034, 752 cm-1; LRMS 
(ES+) m/z = 291.1 [M+Na]+. 
 
Methyl tetrahydro-4-((R)-3,4-dihydro-6-methoxy-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18e). Method B: The 
reaction was run on 0.30 mmol scale for 24 h. The crude material was purified by silica gel 
chromatography (1:4 EtOAc:Hexanes) to give 87 mg (95% yield) of 18e as a white solid. The 
enantiomeric excess was determined to be 88% by chiral HPLC analysis (CHIRALPAK AS-H, 1.0 
mL/min, 5% IPA in Hexanes, λ = 210 nm): tR(major) = 12.1 min, tR(minor) = 10.6 min. [α]D26 = –
132.1° (c = 0.88, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 6.88 (d, J=8.2 Hz, 1 H), 6.73 (dd, J=8.5, 2.5 Hz, 1 H), 6.65 (d, 
J=2.7 Hz, 1 H), 4.95 (s, 1 H), 4.12 (ddd, J=10.6, 4.9, 1.8 Hz, 1 H), 3.83 (dd, J=11.7, 3.0 Hz, 2 H), 3.79 (s, 3 H), 3.74 (s, 3 H), 
3.51 (ddd, J=11.0, 2.3 Hz, 1 H), 3.36-3.47 (m, 2 H), 2.90 (ddd, J=15.9, 11.6, 5.0 Hz, 1 H), 2.49 (d, J=15.6 Hz, 1 H), 2.00 (dd, 
J=13.3, 1.8 Hz, 1 H), 1.78-1.87 (m, 2 H), 1.73 (ddd, J=13.5, 13.5, 5.0 Hz, 1 H); 13C NMR (CDCl3, 126 MHz) δ 175.1, 158.2, 
138.2, 127.6, 125.3, 113.5, 111.8, 80.2, 65.4, 65.3, 63.6, 55.2, 52.6, 51.8, 30.6, 29.7, 29.6; FTIR (NaCl, thin film) 2956, 
2854, 1732, 1611, 1503, 1446, 1284, 1259, 1245, 1219, 1195, 1134, 1102, 1035 cm-1; LRMS (ES+) m/z = 329.1 [M+Na]+. 
 
Methyl 4-((R)-6-fluoro-3,4-dihydro-1H-isochromen-1-yl)-tetrahydro-2H-pyran-4-carboxylate (18f). Method B: The 
reaction was run on 0.30 mmol scale for 21h. The crude material was purified by silica gel 
chromatography (1:5 EtOAc:Hexanes) to give 62 mg (70% yield) of 18f as a white solid. The 
enantiomeric excess was determined to be 95% by chiral HPLC analysis (CHIRALPAK AD-H, 1.0 
mL/min, 5% EtOH in Hexanes, λ = 210 nm): tR(major) = 13.1 min, tR(minor) = 15.7 min. [α]D26 = –
106.0° (c = 1.0, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 6.92 (dd, J=8.5, JH-F=5.5 Hz, 1 H), 6.87 (ddd, J=8.5, 2.0, JH=F=8.5 
Hz, 1 H), 6.83 (dd, J=2.5, JH-F=9.0 Hz, 1 H), 4.95 (s, 1 H), 4.13 (ddd,  J=10.5, 5.0, 1.5 Hz, 1 H), 3.83 (dd, J=11.5, 4.0 Hz, 2 
H), 3.73 (s, 3 H), 3.50 (ddd, J=11.0, 11.0, 2.5 Hz, 1 H), 3.41 (m, 2 H), 2.90 (ddd, J=15.5, 11.5, 5.0 Hz, 1 H), 2.51 (d,  J=15.5 
Hz, 1 H), 1.99 (dd, J=13.5 Hz, 2.0 Hz, 1 H), 1.77 (m, 3 H); 13C NMR (CDCl3, 126 MHz) δ 174.8, 161.4 (d, JC-F=246.2 Hz), 
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139.1 (d, JC-F=7.3 Hz), 128.9 (d, JC-F=2.76 Hz), 128.0 (d, JC-F=Hz), 115.1 (d, JC-F=21.1 Hz), 113.0 (d, JC-F=22.0 Hz), 80.1, 
65.3, 65.2, 63.4, 52.5, 51.9, 30.3, 29.9, 29.5; IR (NaCl, thin film): 2956, 2940, 2857, 1732, 1616, 1499, 1238, 1220, 1196, 
1135, 1102 cm-1; LRMS (ES+) m/z = 317.1 [M+Na]+. 
 
Methyl tetrahydro-4-((R)-3,4-dihydro-5-methyl-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18g). Method B: The 
reaction was run on 0.30 mmol scale for 24 h. The crude material was purified by silica gel 
chromatography (1:9 EtOAc:Hexanes) to give 62 mg (70% yield) of 18g as a viscous colorless oil. The 
enantiomeric excess was determined to be 97% by chiral HPLC analysis (Chiralcel OD-H, 1.0 mL/min, 
5% IPA in Hexanes, λ = 210 nm): tR(major) = 9.8 min, tR(minor) = 7.9 min. [α]D26 = –83.5° (c = 0.52, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.08 (s, 1 H), 7.09 (dd, J=9.4, 8.0 Hz, 1 H), 6.79-6.84 (m, 1 H), 
5.01 (s, 1 H), 4.18 (ddd, J=10.8, 5.2, 1.9 Hz, 1 H), 3.79-3.86 (m, 2 H), 3.75 (s, 3 H), 3.55 (ddd, J=11.0, 2.6 Hz, 1 H), 3.38-
3.47 (m, 2 H), 2.72 (ddd, J=16.2, 11.3, 5.0 Hz, 1 H), 2.56 (ddd, J=16.0, 1.8 Hz, 1 H), 2.26 (s, 3 H), 2.00 (ddd, J=13.5, 4.1, 
2.1 Hz, 1 H), 1.71-1.85 (m, 3 H); 13C NMR (CDCl3, 126 MHz) δ 174.8, 135.3, 135.0, 132.9, 128.0, 125.0, 123.7, 80.1, 65.1, 
65.0, 63.2, 52.4, 51.5, 29.7, 29.1, 26.8, 18.8; FTIR (NaCl, thin film) 2955, 2855, 1732, 1468, 1446, 1219, 1196, 1139, 1108, 
1080, 1034 cm-1; LRMS (ES+) m/z = 313.1 [M+Na]+. 
 
Methyl tetrahydro-4-((R)-3,4-dihydro-6-methyl-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18h). Method B: The 
reaction was run on 0.30 mmol for 27 h. The crude material was purified by silica gel 
chromatography (1:9 EtOAc:Hexanes) to give 66 mg (76% yield) of 18h as a white solid. The 
enantiomeric excess was determined to be 94% by chiral HPLC analysis (CHIRALPAK AS-H, 1.0 
mL/min, 2% EtOH in Hexanes, λ = 210 nm): tR(major) = 6.5 min, tR(minor) = 6.1 min. [α]D26 = –
108.4° (c = 0.89, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 6.99 (d, J=8.2 Hz, 1 H), 6.94 (s, 1 H), 6.85 
(d, J=7.8 Hz, 1 H), 4.97 (s, 1 H), 4.13 (ddd, J=10.5, 5.0, 1.8 Hz, 1 H), 3.83 (dd, J=11.4, 3.7 Hz, 2 H), 3.75 (s, 3 H), 3.52 (ddd, 
J=11.0, 11.0, 2.3 Hz, 1 H), 3.38-3.48 (m, 2 H), 2.89 (ddd, J=15.8, 11.4, 4.8 Hz, 1 H), 2.49 (d, J=15.6 Hz, 1 H), 2.32 (s, 3 H), 
2.01 (d, J=12.8 Hz, 1 H), 1.79-1.85 (m, 2 H), 1.74 (ddd, J=13.2, 4.8 Hz, 1 H); 13C NMR (CDCl3, 126 MHz) δ 175.3, 136.8, 
136.7, 130.5, 129.4, 126.9, 126.6, 80.6, 65.6, 65.5, 64.0, 52.8, 52.0, 30.5, 30.0, 29.8, 21.2; FTIR (NaCl, thin film) 2956, 
2856, 1733, 1446, 1218, 1194, 1134, 1100, 1034, 842 cm-1; LRMS (ES+) m/z = 292.2 [M+H]+. 
 
Methyl tetrahydro-4-((R)-3,4-dihydro-7-methyl-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18i). Method B: The 
reaction was run on 0.30 mmol for 20h. The crude material was purified by silica gel chromatography 
(1:9 EtOAc:Hexanes) to give 61 mg (70% yield) of 18i as a white solid. The enantiomeric excess was 
determined to be 92% by chiral HPLC analysis (CHIRALPAK AS-H, 1.0 mL/min, 2% EtOH in 
Hexanes, λ = 210 nm): tR(major) = 6.3 min, tR(minor) = 6.0 min. [α]D26 = –120.6° (c = 0.52, CHCl3); 
1H NMR (CDCl3, 500 MHz) δ 7.00 (m, 2 H), 6.75 (s, 1 H), 4.94 (s, 1 H), 4.12 (ddd, J=10.5, 5.0, 2.0 Hz, 1 H), 3.81-3.85 (m, 
2 H), 3.75 (s, 3 H), 3.49 (ddd, J= 12.0, 12.0, 2.0 Hz, 1 H)  3.37-3.48 (m, 2 H), 2.86 (ddd, J=16.5, 12.0, 5.0 Hz, 1 H), 2.48 (d, 
J=15.5 Hz, 1 H), 2.31 (s, 3 H), 2.01 (dd, J=13.5, 2.0 Hz, 1 H), 1.79-1.86 (m, 2 H), 1.72 (ddd, J=13.0, 13.0, 5.0 Hz, 1 H); 13C 
NMR (CDCl3, 126 MHz) δ 175.1, 135.2, 133.7, 133.0, 128.3, 127.6, 127.1, 80.4, 65.3, 65.3, 63.9, 52.7, 51.7, 29.9, 29.6, 
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29.4, 21.2; FTIR (NaCl, thin film): 2952, 2876, 2857, 1723, 1506, 1444, 1217, 1194, 1132, 1101 cm-1; LRMS (ES+) m/z = 
313.1 [M+Na]+. 
 
Assignment of absolute stereochemistry: saponification of isopropyl 2-(3,4-dihydro-1H-isochromen-1-yl)acetate (9a). 
To a solution of 9a (30 mg, 0.13 mmol, 1.0 equiv; 82% ee) in MeOH (0.75 mL) was added 0.5 M LiOH 
(1.0 mL, 1.0 mmol, 3.8 equiv). The reaction was stirred at room temperature for 15 h, then acidified by 
addition of 0.5 M citric acid (1.5 mL). The MeOH was removed under reduced pressure, and the aqueous 
residue was partitioned with CH2Cl2 (3 X 10 mL). The organics were washed once with brine (15 mL), 
and dried over Na2SO4. Filtration followed by rotary evaporation under reduced pressure provided a crude residue that was 
purified by sílica gel chromatography provide 9a (21 mg, 85% yield) as a colorless oil. The 1H NMR data were identical to 
that reported by TenBrink and coworkers.4 [α]D29 = –85° (c = 1.05, CH2Cl2). The observed rotation corresponds to product of 
65% ee, indicating that some epimerization occured under the saponification conditions. TenBrink and coworkers report [α]D 
= –132° (c = 0.98, CH2Cl2) for (S)-(−)-(isochroman-1-yl)acetic acid.  
 
                                                 
4 TenBrink, R. E.; Bergh, C. L.; Duncan, J. N.; Harris, D. W.; Huff, R. M.; Lahti, R. A.; Lawson, C. F.; Lutzke, B. S.; Martin, 
I. J.; Rees, S. A.; Schlachter, S. K.; Sih, J. C.; Smith, M. W. J. Med. Chem. 1996, 39, 2435-2437. 
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D. Chromatograms of racemic and enantiomerically enriched isochromans. 
 
Methyl 2-((S)-3,4-dihydro-1H-isochromen-1-yl)acetate (9b). 
 
Racemic 9b ((S,S)-Whelk-01 (Pirkle), 98:2 hexane:i-PrOH, 1 mL/min, λ=210 nm): 
 
 
Enantiomerically enriched 9b (85% ee): 
 
 
 
O
CO2Me
9b
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Methyl 2-((S)-3,4-dihydro-5-methyl-1H-isochromen-1-yl)acetate (9c). 
 
Racemic 9c ((S,S)-Whelk-01 (Pirkle), 98:2 hexane:i-PrOH, 1 mL/min, λ=210 nm): 
 
 
Enantiomerically enriched 9c (90% ee): 
 
 
O
CO2Me
Me
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Methyl 2-((S)-3,4-dihydro-6-methyl-1H-isochromen-1-yl)acetate (9d) 
 
Racemic 9d (CHIRALPAK AS-H, 98:2 hexane:EtOH, 1 mL/min, λ=210 nm): 
 
 
Enantiomerically enriched 9d (84% ee): 
 
 
 
O
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Methyl 2-((S)-3,4-dihydro-7-methyl-1H-isochromen-1-yl)acetate (9e). 
 
Racemic 9e ((S,S)-Whelk-01 (Pirkle), 98:2 hexane:i-PrOH, 1 mL/min, λ=210 nm): 
 
 
Enantiomerically enriched 9e (87% ee): 
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Methyl 2-((S)-6-fluoro-3,4-dihydro-1H-isochromen-1-yl)acetate (9f).  
 
Racemic 9f (S,S-Whelk-01 (Pirkle), 98:2 Hexanes:i-PrOH, 1 mL/min, λ = 210 nm):  
 
 
Enantiomerically enriched 9f (90% ee): 
 
 
O
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Methyl 2-((S)-3,4-dihydro-6-methoxy-1H-isochromen-1-yl)acetate (9g).  
 
Racemic 9g (CHIRALPAK AD-H, 95:5 Hexane:i-PrOH, 1 mL/min, λ = 210 nm): 
 
 
Enantiomerically enriched 9g (74% ee): 
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Methyl 2-(3,4-dihydro-1H-isochromen-1-yl)-2-methylpropanoate (18a).  
Racemic 18a (β-cyclodex, 7 psi, 105 °C, isothermal): 
 
 
Enantiomerically enriched 18a (92% ee): 
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Methyl 1-(3,4-dihydro-1H-isochromen-1-yl)cyclohexanecarboxylate (18b).  
 
Racemic 18b (Chiralcel OD-H, 99:1 Hexane:i-PrOH, 0.5 mL/min, λ = 210 nm): 
 
 
Enantiomerically enriched 18b (94% ee): 
 
 
O
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Methyl 1-((R)-3,4-dihydro-1H-isochromen-1-yl)cyclopentanecarboxylate (18c).  
 
Racemic 18c (CHIRALPAK AD-H, 98:2 Hexane:i-PrOH, 1.0 mL/min, λ = 210 nm):  
 
 
Enantiomerically enriched 18c (92% ee): 
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Methyl tetrahydro-4-((R)-3,4-dihydro-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18d).  
 
Racemic 18d (Chiralcel OD-H, 95:5 Hexanes:i-PrOH, 1.0 mL/min, λ = 210 nm): 
 
 
Enantiomerically enriched 18d (93% ee): 
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Methyl tetrahydro-4-((R)-3,4-dihydro-6-methoxy-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18e).  
 
Racemic 18e (CHIRALPAK AS-H, 95:5 Hexanes:i-PrOH, 1.0 mL/min, 5λ = 210 nm): 
 
 
Enantiomerically enriched 18e (88% ee): 
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Methyl 4-((R)-6-fluoro-3,4-dihydro-1H-isochromen-1-yl)-tetrahydro-2H-pyran-4-carboxylate (18f).  
 
Racemic 18f (CHIRALPAK AD-H, 95:5 Hexane:EtOH, 1.0 mL/min, λ = 210 nm): 
 
 
Enantiomerically enriched 18f (95% ee): 
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Methyl tetrahydro-4-((R)-3,4-dihydro-5-methyl-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18g).  
 
Racemic 18g (Chiralcel OD-H, 95:5 Hexanes:i-PrOH, 1.0 mL/min, λ = 210 nm): 
 
 
Enantiomerically enriched 18g (97% ee): 
 
 
O
Me
MeO2C O
18g
 S28 
Methyl tetrahydro-4-((R)-3,4-dihydro-6-methyl-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18h).  
 
Racemic 18h (CHIRALPAK AS-H, 98:2 Hexanes:EtOH, 1.0 mL/min, λ = 210 nm): 
 
 
Enantiomerically enriched 18h (94% ee): 
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Methyl tetrahydro-4-((R)-3,4-dihydro-7-methyl-1H-isochromen-1-yl)-2H-pyran-4-carboxylate (18i).  
 
Racemic 18i (CHIRALPAK AS-H, 98:2 Hexanes:EtOH), 1.0 mL/min, λ = 210 nm):  
 
 
Enantiomerically enriched 18i (92% ee): 
 
 
O
Me
MeO2C O
18i
 S30 
E. General procedure for the preparation of substituted isochromans: preparation of 3,4-dihydro-5-methyl-1H-
isochromene.5  
Me
OH
1. MOMCl, 
DIPEA, CH2Cl2
2. TMSOTf (10 mol%), 
MeCN
Me
O
 
A solution of 2-methylphenethyl alcohol (2.7 mL, 20.0 mmol, 1.0 equiv) in CH2Cl2 (40 mL) was cooled to 0 ºC and 
DIPEA (10.5 mL, 60.0 mmol, 3.0 equiv) was added followed by MOM-Cl (2.3 mL, 30.0 mmol, 1.5 equiv). The reaction was 
warmed to room temperature and stirred for 14 h. The reaction was diluted with Et2O (40 mL), washed once with aqueous 1N 
HCl (20 mL), once with saturated aq. NaHCO3 (20 mL), once with brine (20 mL), and dried over Na2SO4. Filtration followed 
by concentration under reduced pressure provided 3.4g (94% yield) of 1-(2-(methoxymethoxy)ethyl)-2-methylbenzene. The 
material <95% pure by 1H NMR analysis, and was used crude in the following step.  
 In an oven-dried 100 mL flask, 1.4 g of 1-(2-(methoxymethoxy)ethyl)-2-methylbenzene was dried by azeotrope with 
benzene (5 mL). The residue was dissolved in MeCN (40 mL), cooled to 0 ºC, and TMSOTf (0.14 mL, 0.78 mmol, 0.1 equiv) 
was added dropwise. The reaction was warmed to room temperature and stirred an additional 5 h, then quenched by addition 
of saturated aqueous NaHCO3 (10 mL). The MeCN was removed under reduced pressure and the aqueous later was diluted 
with 10 mL saturated aqueous NaHCO3, then partitioned with Et2O (3 x 20 mL). The ethereal layer was dried over Na2SO4, 
filtered, and concentrated to give the crude material as a yellow oil. The crude product was purified by silica gel 
chromatography (gradient elution, 1:9 Et2O:hexanes) to give 1.0g (86% yield) of 3,4-dihydro-5-methyl-1H-isochromene as a 
colorless oil. 1H NMR (CDCl3, 500 MHz) δ 7.12 (t, J=7.3 Hz, 1 H), 7.05 - 7.09 (m, J=7.6 Hz, 1 H), 6.87 (d, J=7.6 Hz, 1 H), 
4.80 (s, 2 H), 4.05 (t, J=5.8 Hz, 2 H), 2.75 (t, J=5.8 Hz, 2 H), 2.27 (s, 3 H); (CDCl3, 126 MHz) δ 135.5, 134.7, 130.0, 128.7, 
127.1, 124.8, 67.9, 65.5, 27.9, 21.0; FTIR (NaCl, thin film) 2958, 2923, 2856, 1505, 1448, 1429, 1377, 1227, 1105, 950, 810 
cm-1; LRMS (ES+) m/z: 149.1 [M+H]+. 
 
 3,4-dihydro-6-methyl-1H-isochromene and 3,4-dihydro-8-methyl-1H-isochromene. Followed cyclization procedure 
from crude 1-(2-(methoxymethoxy)ethyl)-3-methylbenzene on 3.3 mmol scale and 
purified using silica gel chromatography (1:9 Et2O: Hexanes) to give 362 mg (74% 
yield) of an inseparable 2:1 mixture of 3,4-dihydro-6-methyl-1H-isochromene and 
regioisomeric 3,4-dihydro-8-methyl-1H-isochromene as a colorless oil. The oil was characterized as a mixture and carried on 
to the subsequent step. 1H NMR (CDCl3, 500 MHz; 3,4-dihydro-6-methyl-1H-isochromene is designated by *, 3,4-dihydro-8-
methyl-1H-isochromene is designated by §) δ 7.11 (t, J=7.6 Hz, 1 H§), 6.97 - 7.03 (m, 1H*, 2 H§), 6.96 (s, 1 H*), 6.89 (d, 
J=7.8 Hz, 1 H*), 4.76 (s, 2 H*), 4.73 (s, 2 H§), 3.98 (t, J=5.7 Hz, 2 H*), 3.96 (t, J=5.6 Hz, 2 H§), 2.88 (t, J=5.6 Hz, 2 H§), 
2.84 (t, J=5.7 Hz, 2 H*), 2.33 (s, 3 H*), 2.16 (s, 3 H§); 13C NMR (CDCl3, 126 MHz; signals for both 3,4-dihydro-6-methyl-
1H-isochromene and 3,4-dihydro-8-methyl-1H-isochromene are included) δ 135.8, 133.4, 133.2, 133.1, 133.0, 131.9, 129.4, 
127.5, 126.8, 126.5, 126.1, 124.3, 67.9, 66.5, 65.4, 64.9, 28.7, 28.3, 21.0, 17.8; FTIR (NaCl, thin film) 2962, 2925, 
2850,1505, 1464, 1382, 1113, 1102, 950, 859, 797, 770 cm-1; LRMS (ES+) m/z: 149.1 [M+H]+. 
 
                                                 
5 DeNinno, M.P.; Perner, R.J.; Morton, H.E.; DiDomenico, S. J. Org. Chem. 1992, 57, 7115-7118. 
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 3,4-dihydro-7-methyl-1H-isochromene. Followed cyclization procedure from crude 1-(2-(methoxymethoxy)ethyl)-4-
methylbenzene on 5.0 mmol scale and purified using silica gel chromatography (1:9 Et2O: Hexanes) to 
give 557 mg (68% yield) of 3,4-dihydro-7-methyl-1H-isochromene as a colorless oil. 1H NMR (CDCl3, 
500 MHz) δ 7.04 (d, J=7.8 Hz, 1 H), 7.01 (d, J=8.0 Hz, 1 H), 6.83 (s, 1 H), 4.77 (s, 2 H), 3.99 (t, J=5.7 Hz, 2 H), 2.85 (t, 
J=5.7 Hz, 2 H), 2.33 (s, 3 H); 13C NMR (CDCl3, 126 MHz) δ 136.4, 134.7, 131.7, 127.6, 125.6, 122.0, 68.3, 65.5, 26.1, 18.7; 
FTIR (NaCl, thin film) 2961, 2922, 2851, 2830, 1472, 1384, 1237, 1116, 1065, 1004, 912, 855, 769 cm-1, LRMS (ES+) m/z: 
149.1 [M+H]+ 
 
 3,4-dihydro-6-fluoro-1H-isochromene. Followed cyclization procedure from crude 1-fluoro-3-(2-
(methoxymethoxy)ethyl)benzene on 2.7 mmol scale and purified using silica gel chromatography (1:9 
Et2O: Hexanes) to give 301 mg (73% yield) of 3,4-dihydro-6-fluoro-1H-isochromene as a colorless oil. 1H 
NMR (CDCl3, 600 MHz) δ 6.84 (dd, J=8.2, JH-F=5.7 Hz, 1 H), 6.77 (ddd, J=8.5, 2.3 JH-F=8.5 Hz, 1 H), 6.73 (d, JH-F=9.4 Hz, 
1 H), 4.64 (s, 2 H), 3.86 (t, J=5.7 Hz, 2 H), 2.75 (t, J=5.7 Hz, 2 H); 13C NMR (CDCl3, 126 Mhz) δ 161.3 (d, JC-F = 244.5 Hz), 
135.3 (d, JC-F = 7.3 Hz), 130.4 (d, JC-F = 2.8 Hz), 125.9 (d, JC-F = 7.3 Hz), 115.2 (d, JC-F = 21.1 Hz), 113.1 (d, JC-F = 21.1 Hz), 
67.6, 64.9, 28.4 (d, JC-F = 2.4 Hz); FTIR (NaCl, thin film) 2927, 2873, 1617, 1591, 1515, 1490, 1451, 1247, 1149, 1110, 
1073, 1033, 921, 810, 783 cm-1; LRMS (ES+) m/z = 153.1 [M+H]+. 
 
 3,4-dihydro-6-methoxy-1H-isochromene. Followed cyclization procedure from crude 1-methoxy-3-(2-
(methoxymethoxy)ethyl)benzene on 30.0 mmol scale and purified by silica gel chromatography (1:9 
EtOAc:Hexanes) to give 2.8g (56% yield) of 3,4-dihydro-6-methoxy-1H-isochromene as a colorless oil. 
1H NMR (CDCl3, 500 MHz) δ 6.91 (d, J=8.5 Hz, 1 H), 6.76 (dd, J=8.4, 2.6 Hz, 1 H), 6.68 (d, J=2.3 Hz, 1 
H), 4.74 (s, 2 H), 3.97 (t, J=5.7 Hz, 2 H), 3.80 (s, 3 H), 2.85 (t, J=5.6 Hz, 2 H); 13C NMR (CDCl3, 126 MHz) 158.0, 134.3, 
127.0, 125.3, 113.4, 112.2, 67.6, 65.1, 55.1, 28.5; FTIR (NaCl, thin film) 2956, 2934, 2835, 1611, 1504, 1453, 1382, 1313, 
1274, 1243, 1157, 1102, 1038, 855, 811 cm-1; LRMS (ES+) m/z = 165.1 [M+H]+. 
 
General procedure for DDQ oxidation of isochromans: preparation of 1-methoxyisochroman (6).6,7 
O O
DDQ, MeOH, CH2Cl2
OMe  
To a solution of DDQ (2.1 g, 9.3 mmol, 1.2 equiv) in CH2Cl2 (50 mL) was added anhydrous methanol (0.36 mL, 9.3 mmol, 
1.2 equiv) followed by isochroman (1.06 g, 7.91 mmol, 1.0 equiv). The bright red heterogeneous mixture was stirred 
vigorously under N2 at room temperature for 24 h, then quenched by addition of aqueous saturated NaHCO3 (60 mL). The 
heterogeneous mixture was filtered through celite and rinsed with an additional CH2Cl2 (50 mL). The aqueous layer was 
separated and partitioned twice with 30 mL CH2Cl2, and the combined organic extracts were washed once with aqueous 
saturated NaHCO3 (30 mL), once with brine (30 mL), and dried over anhydrous MgSO4. The pale yellow crude oil was 
                                                 
6 Xu, Y. C.; Lebeau, E.; Gillard, J. W.; Attardo, G. Tetrahedron Lett. 1993, 34, 3841-3844. 
7 For a DDQ-mediated direct coupling of isochroman with ketones to provide racemic 1-substituted isochromans, see: Zhang, 
Y.; Li, Chao, Jun. J. Am. Chem. Soc. 2006, 128, 4242-4243. 
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purified by silica gel chromatography (10% Et2O-Hexanes) to give 1.01 g (83% yield) of 1-methoxyisochroman (6) as a 
colorless oil. The product can also be purified by distillation through a Vigreoux column (bp = 108 °C at 15 torr). 1H NMR 
(400 MHz, CDCl3) δ 7.24 - 7.38 (m, 3 H), 7.10 - 7.22 (m, 1 H), 5.52 (s, 1 H), 4.19 (ddd, J=11.6, 11.6, 3.5 Hz, 1 H), 3.97 
(ddd, J=11.4, 6.0, 1.6 Hz, 1 H), 3.61 (s, 3 H), 3.09 (ddd, J=17.2, 12.1, 5.9 Hz, 1 H), 2.68 (dd, J=14.8, 1.6 Hz, 1 H); 13C NMR 
(100 MHz, CDCl3) δ134.4, 134.3, 128.7, 128.4, 127.7, 126.6, 98.0, 58.0, 55.6, 28.2; FTIR (NaCl/thin film) 2967, 2936, 2883, 
2827, 1457, 1383, 1355, 1275, 1208, 1188, 1075, 1050, 1033, 945, 954, 780, 749 cm-1; LRMS (ES+) m/z = 133.1 [M–
OMe]+. 
  
3,4-dihydro-1-methoxy-5-methyl-1H-isochromene (6b). Followed the general procedure on 6.7 mmol scale and purified by 
silica gel chromatography (1:9 to 1:3 Et2O:Hexanes) to give 830 mg (70% yield) of 3,4-dihydro-1-methoxy-5-
methyl-1H-isochromene as a white solid. This material contains 1-4% of the starting 3,4-dihydro-5-methyl-1H-
isochromene. 1H NMR (CDCl3, 500 MHz) δ 7.08 - 7.22 (m, 3 H), 5.47 (s, 1 H), 4.18 (ddd, J=11.6, 11.6, 3.8 
Hz, 1 H), 4.00 (ddd, J=11.4, 6.4, 1.6 Hz, 1 H), 3.58 (s, 3 H), 2.84 (ddd, J=17.4, 11.9, 6.4 Hz, 1 H), 2.58 (ddd, 
J=16.7, 3.7, 1.4 Hz, 1 H), 2.26 (s, 3 H); 13C NMR (CDCl3, 126 MHz) δ 135.9, 133.9, 132.4, 129.4, 125.9, 125.0, 98.0, 57.4, 
55.3, 25.6, 18.8; FTIR (NaCl, thin film) 2966, 2931, 2882, 2825, 1471, 1386, 1343, 1186, 1108, 1075, 1051, 955, 782, 727 
cm-1; LRMS (ES+) m/z: 147.3 [M–OMe]+. 
 
3,4-dihydro-1-methoxy-5-methyl-1H-isochromene (6b). Note: A 2:1 mixture of 3,4-dihydro-6-methyl-1H-isochromene 
and 3,4-dihydro-8-methyl-1H-isochromene was employed on 5.7 mmol scale. The selective oxidation of 
3,4-dihydro-6-methyl-1H-isochromene was possible by modification of the general procedure to use only 
0.67 equiv DDQ. The product was purified by careful silica gel chromatography (1:20 Et2O:Hexanes, run 
through two columns) to give 323 mg (48% yield based on 3,4-dihydro-6-methyl-1H-isochromene) of 3,4-dihydro-1-
methoxy-5-methyl-1H-isochromene as a colorless oil. 1H NMR (CDCl3, 500 MHz) δ 7.16 (d, J=7.8 Hz, 1 H), 7.06 (d, J=7.8 
Hz, 1 H), 6.96 (s, 1 H), 5.46 (s, 1 H), 4.13 (ddd, J=11.6, 11.6, 3.4 Hz, 1 H), 3.92 (ddd, J=11.2, 6.0, 1.8 Hz, 1 H), 3.56 (s, 3 
H), 3.01 (ddd, J=16.9, 11.9, 6.0 Hz, 1 H), 2.60 (dd, J=16.5, 1.6 Hz, 1 H), 2.34 (s, 3 H); 13C NMR (CDCl3, 126 Mhz) δ 137.8, 
133.8, 131.2, 128.8, 127.2, 127.1, 97.7, 57.7, 55.2, 27.9, 21.1; FTIR (NaCl, thin film) 2927, 2880, 2825, 1619, 1382, 1355, 
1187, 1132, 1091, 1075, 1048, 961, 807 cm-1; LRMS (ES+) m/z  147.1 [M–OMe]+. 
 
 3,4-dihydro-1-methoxy-7-methyl-1H-isochromene (6d). Followed the general procedure on 4.6 mmol scale and purified 
by silica gel chromatography (1:9 Et2O:Hexanes) to give 454 mg (60% yield) of 3,4-dihydro-1-methoxy-7-
methyl-1H-isochromene as a white solid. 1H NMR (CDCl3, 500 MHz) δ 7.05 - 7.13 (m, 2 H), 7.03 (d, 
J=8.3 Hz, 1 H), 5.43 (s, 1 H), 4.12 (ddd, J=11.7, 3.4 Hz, 1 H), 3.91 (dd, J=11.2, 5.9 Hz, 1 H), 3.56 (s, 3 H), 
3.00 (ddd, J=16.6, 12.2, 5.9 Hz, 1 H), 2.59 (d, J=16.1 Hz, 1 H), 2.33 (s, 3 H); 13C NMR (CDCl3,126 MHz) 
δ 135.9, 133.8, 130.9, 129.1, 128.3, 127.7, 97.8, 57.9, 55.3, 27.6, 21.0; FTIR (NaCl, thin film) 2928, 2879, 2826, 1505, 1352, 
1158, 1095, 1074, 1049, 957, 812 cm-1;  LRMS (ES+) m/z: 147.3 [M–OMe]+. 
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 6-fluoro-3,4-dihydro-1-methoxy-1H-isochromene (6e). Followed the general procedure on 2.6 mmol 
scale and purified by silica gel chromatography (1:19 Et2O:Hexanes) to give 303 mg (63% yield) of 6-
fluoro-3,4-dihydro-1-methoxy-1H-isochromene as a colorless oil. This material contains 1-4% of the 
starting 6-fluoro-3,4-dihydro-1H-isochromene. 1H NMR (CDCl3, 500 MHz) δ 7.22 (dd, J=8.5, JH-F = 5.6 Hz, 1 H), 6.93 (ddd, 
J=8.5, 2.4, JH-F=8.5 Hz, 1 H), 6.83 (dd, J=2.0, JH-F= 9.3 Hz, 1 H), 5.43 (s, 1 H), 4.10 (ddd, J=11.5, 11.5, 3.4 Hz, 1 H), 3.90 
(dd, J=11.5, 6.1 Hz, 1 H), 3.54 (s, 3 H), 3.02 (ddd, J=17.1, 12.2, 6.3 Hz, 1 H), 2.62 (dd, J=16.6, 2.0 Hz, 1 H); 13C NMR 
(CDCl3, 126 MHz) δ 162.2 (d, JC-F=247.1 Hz), 136.5, 130.1, 129.3 (d, JC-F=8.5 Hz), 114.7 (d, JC-F=20.5 Hz), 113.7 (d, JC-
F=21.3 Hz), 97.4, 57.2, 55.3, 28.1 (d, JC-F=1.8 Hz); FTIR (NaCl, thin film) 2936, 2983, 1621, 1593, 1500, 1384, 1272, 1240, 
1107, 1075, 1050, 1000, 964, 837 cm-1, LRMS (ES+) m/z 151.0 [M–OMe]+.  
 
 6-methoxy-3,4-dihydro-1-methoxy-1H-isochromene (6e). Followed the general procedure on 2.6 mmol scale and purified 
by silica gel chromatography (5:1 EtOAc:Hexanes) to give 307 mg (55% yield) of 6-methoxy-3,4-
dihydro-1-methoxy-1H-isochromene as a white solid. 1H NMR (CDCl3, 500 MHz) δ 7.17 (d, J=8.5 Hz, 
1 H), 6.79 (dd, J=8.5, 2.5 Hz, 1 H), 6.65 (d, J=2.3 Hz, 1 H), 5.43 (s, 1 H), 4.11 (ddd, J=11.6, 11.6, 3.4 
Hz, 1 H), 3.89 (ddd, J=11.3, 6.1, 1.6 Hz, 1 H), 3.79 (s, 3 H), 3.53 (s, 3 H), 3.01 (ddd, J=17.2, 12.1, 6.2 Hz, 1 H), 2.60 (dd, 
J=16.6, 1.7 Hz, 1 H); 13C NMR (126 MHz) δ 159.2, 135.5, 128.6, 126.7, 112.8, 112.7, 97.7, 57.5, 55.2, 55.1, 28.3; FTIR 
(NaCl, thin film) 2937, 2881, 2828, 1612, 1504, 1466, 1382, 1321, 1277, 1248, 1127, 1074, 1046, 959, 835 cm-1; LRMS 
(ES+) m/z = 163.1 [M–OMe]+. 
 
Preparation of 1-chloroisochroman (7a). 
O
Cl
O
OMe6 7a
BCl3, CH2Cl2
 
 A flame-dried 25 mL flask was charged with 1-methoxyisochroman (6, 1.52g, 9.29 mmol, 1.0 equiv) and flushed 
with N2, then CH2Cl2 was added (7.4 mL). The solution was cooled to 0 °C and BCl3 (1.0 M solution in hexanes, 3.7 mL, 3.7 
mmol, 0.4 equiv) was added dropwise over 5 min. A yellow precipitate was observed, and the mixture was stirred 5 min at 0 
°C then warmed to room temperature. After 5 min at room temperature, the reaction was a homogenous pale yellow solution. 
Stirring was continued for 1.5 h, after which time the reaction flask was quickly fitted with an oven-dried vac-transfer tube 
and receiving flask under N2, the receiving flask was cooled to –78 °C, and the solvent was removed in vacuo (1 torr). Once 
the solvent was removed, the system was back-filled with N2 and the vac-transfer tube was quickly exchanged for an oven-
dried short path distillation head. The crude yellow oil was distilled in vacuo to give 7a as a viscous, colorless oil (1.15 g, 
74% yield, bp=78 °C at 0.5 torr). 1H NMR (C6D6, 500 MHz) δ 7.00 (dd, J=7.1, 1.8 Hz, 1 H), 6.93 (s, 1 H), 6.85 - 6.92 (m, 2 
H), 6.66 (dd, J=6.9 Hz, 1 H), 4.14 (ddd, J=11.7, 11.7, 3.2 Hz, 1 H), 3.62 (dd, J=11.3, 6.3 Hz, 1 H), 2.57 (ddd, J=16.9, 13.0, 
6.4 Hz, 1 H), 1.90 - 2.02 (m, 1 H); 1H NMR (CDCl3, 500 MHz) δ 7.22 - 7.32 (m, 3 H), 7.16 (s, 1 H), 7.14 (d, J=6.4 Hz, 1 H), 
4.38 (br. s, 1 H), 4.17 (br. s, 1 H), 3.14 (br. s, 1 H), 2.76 (br. s, 1 H); 13C NMR (C6D6, 126 MHz) δ 135.0, 132.1, 128.9, 128.5, 
127.0, 126.7, 93.7, 60.3, 26.9; 13C NMR (CDCl3, 126 MHz) δ 135.6, 132.4, 128.7, 128.5, 127.4, 126.7, 93.8, 60.2, 26.9; 
compound readily undergoes hydrolysis under typical FTIR and mass spectrometry conditions.  
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The purified material was stored in a sealed flask under N2 in a –80 °C freezer. 1-Chloroisochroman (7a) undergoes rapid 
hydrolysis when exposed to moist air to give the dimeric compound S3.8 However, 7a was stored as described above for 4 
months or longer without detectable hydrolysis or decomposition.  
O
O H
O
H
(±)-S3
 
 
F. Thiourea-catalyzed additions to alkyl chloroether substrates. 
 Preliminary results have been obtained for the substitution of silyl ketene acetal 9a to 2-chloro-tetrahydro-2H-pyran 
catalyzed by thiourea 15. Whereas the yields and selectivities observed at –57 °C are modest, reactions conducted under the 
same conditions in the absence of 15 fail to produce any detectable addition product S4. Moreover, experiments conducted in 
the absence of 15 at room temperature still provide <5% S4 after 24h. These data suggest that alkyl chloroethers represent a 
challenging yet viable class of substrates for thiourea-catalyzed substitution reactions. The development of more selective 
catalysts for this type of substrate class is the focus of continued research. 
 
Addition of silyl ketene acetal 9a to 2-chloro-tetrahydro-2H-pyran9 catalyzed by thiourea 15. 
O Cl O Oi-Pr
O
Oi-Pr
OTBS 9a
15 (15 mol%), TBME,
–57 °C, 46 h
(2 equiv)
S4
16% isolated yield
39% ee  
 An oven-dried 10 mL flask was charged with thiourea catalyst (25.8 mg, 0.047 mmol, 0.16 equiv), flushed with N2, 
and TBME (1.0 mL) was added. The flask was cooled to –78 °C and 9b was added (0.150 mL, 0.60 mmol, 2.0 equiv), 
followed by 2-chloro-tetrahydro-2H-pyran (0.40 mL of a 0.73 M stock solution in TBME, 0.29 mmol, 1.0 equiv). The 
reaction was maintained at –57 °C for 46 h, then quenched at that temperature by addition of NaOMe (0.2 mL of 0.5 M 
solution in MeOH). The reaction was diluted with 1 mL of 50% Et2O-Hexanes soution, filtered through a pipette containing 
¾ inch of silica gel (to hydrolyze remaining silyl ketene acetal), and rinsed with 5 mL of the 50% Et2O-Hexanes solution. 
The solvent was removed by rotary evaporation under reduced pressure. Analysis of the crude reaction mixture by 1H NMR 
versus an internal standard determined that isopropyl 2-(tetrahydro-2H-pyran-2-yl)acetate (S4) was formed in 39% yield. 
Purification by silica gel chromatography (1:9 EtOAc:Hexanes) provided S4 (9.0 mg, 16%  yield) as a colorless oil. The 
enantiomeric excess was determined to be 39% by chiral GC analysis (γ-TA, 60° C isothermal, 7 psi): tR(major)=98.0 min, 
                                                 
8 Dimer S3 is a known compound. See reference 6. 
9 Prepared by the method of Viola and coworkers. Viola, A.; Collins, J.J.; Filipp, N.; Locke, J.S. J. Org. Chem. 1993, 58, 
5067–5075. 
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tR(minor)=91.8 min. [α]D27 = 5° (c = 0.45, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 5.03 (sept, J=6.4 Hz, 1 H), 3.95 (ddd, 
J=11.4, 3.9, 2.1 Hz, 1 H), 3.73 (dddd, J=10.3, 7.8, 5.5, 2.3 Hz, 1 H), 3.45 (ddd, J=11.4, 2.7 Hz, 1 H), 2.48 (dd, J=14.9, 7.8 
Hz, 1 H), 2.34 (dd, J=14.9, 5.5 Hz, 1 H), 1.77 - 1.88 (m, 1 H), 1.61 - 1.67 (m, 1 H), 1.46 - 1.60 (m, 3 H), 1.26 - 1.36 (m, 1 H), 
1.23 (dd, J=6.3, 3.5 Hz, 6 H); 13C NMR (CDCl3, 126 MHz) δ 170.9, 74.4, 68.5, 67.7, 42.0, 31.5, 25.7, 25.6, 23.3, 21.8; FTIR 
(NaCl, thin film) 2979, 2937, 2857, 1736, 1375, 1294, 1252, 1169, 1111, 1090, 1046 cm-1; LRMS (ES+) m/z = 209.1 
[M+Na]+.  
To facilitate determination of conversion by 1H NMR analysis of the crude reaction mixtures, the 2-chloro-
tetrahydro-2H-pyran stock solution contained 0.12 equiv of isochroman as an internal standard. 
 
Isopropyl 2-(tetrahydro-2H-pyran-2-yl)acetate (S4). 
 
Racemic S4 (Gamma-TA, 60° C isothermal, 7 psi): 
 
 
Enantiomerically enriched S4 (39% ee): 
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Preliminary efforts toward thiourea catalyst-controlled diastereoselective O-glycosidations 
Methods for stereoselective 2-deoxyglycosyl bond-formation are particularly challenging due to the lack of a 
stereodirecting C–2 substituent that can participate in anchimeric assistance during the bond-forming step.10 2-
Deoxyglycosides are also found in several important antibiotic families, including the erythromycins, and the anthracycline 
and enediyne antibiotics. Considering these two possibilities, we chose to examine 2-deoxy glycosyl donors as substrates for 
the thiourea-catalyzed addition reactions.  
Promising preliminary results were found for O-glycosidation reactions. In particular, significant rate accelerations 
for the addition of alcohols to glycosyl acetates were observed in the presence of thiourea catalyst 14 and 20 mol% BCl3 (SI 
Table 1).11 In the absence of catalyst, addition of methanol to S5 proceeds in only 19% conversion over 48 h at –30 °C and 
results in a 1:1.1 α/β ratio of product S6. By contrast, using (R,S)-14, 1-methoxy S6 was formed in 94% conversion and in 
1:1.7 ratio in favor of the β anomer. Use of the opposite enantiomer of catalyst (S,R)-14 led to a small preference for the 
formation of the α anomer in a 1.4:1 ratio. Analysis of the stereochemical outcome of the reaction is complicated by the fact 
that substrate S5 exists as a mixture of α and β anomers. Recovered starting material from the reactions with (R,S) and (S,R)-
14 showed that the two diastereomers react at different rates with the enantiomeric catalysts. Thus, it is clear that the catalyst 
imparts some degree of stereocontrol in the reaction and experiments are ongoing to improve upon these preliminary results. 
SI Table 1. Doubly diasteroselective O-glycosidation of S5 with chiral thiourea 14. 
 
(R,S)-14
(S,R)-14
conv. (%)a α/β (S6)a
94
56
1:1.7
1.4:1
catalyst
19none 1:1.1
O
H3CO
H3CO
OCH3
OAc O
H3CO
H3CO
OCH3
OCH3catalyst (10 mol%)
BCl3 (20 mol%)
CH3OH (1.5 equiv), 
TBME, −78 to −30 °C to rt
S5 (5.9:1 α/β)
α/β (S5)a
>15:1
8.9:1
>15:1
entry
1
2
S6α
O
H3CO
H3CO
OCH3
OCH3
S6β
O
H3CO
H3CO
OCH3
OAc
S5 (recovered)
3
aDetermined by 1H NMR analysis.  
 
General procedure for the preparation of 3,4,5-tri-O-methyl-2-deoxy glycosyl acetate (S5): 
 
                                                 
10 For a recent review, see: Marzabadi, C. H.; Franck, R. W. Tetrahedron 2000, 56, 8385–8417. 
11 BCl3-catalyzed O-glycosidations have been reported: Toshima, K.; Nagai, H.; Ushiki, Y.; Matsumura, S. Synlett 1998, 
1007–1009. 
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O
H3CO
H3CO
OCH3
OAcO
H3CO
H3CO
OCH3
Ph3P•HBr, AcOH
CH2Cl2
S5 (5.9:1 α/β)
95% yield  
An oven-dried 100 mL round-bottom flask was charged with 3,4,6-tri-O-methyl-D-glucal12 (2.12 g, 11 mmol, 1 
equiv), 55 mL dichloromethane, and a stir bar. Glacial acetic acid (1.0 mL, 16.5 mmol, 1.5 equiv) and PPh3·HBr (189 mg, 
0.55 mmol, 5 mol%) were added. The reaction was stirred for 21.5 hours at room temperature and then the reaction was 
concentrated in vacuo. The residue was purified by column chromatography on silica gel, eluting with 15% to 20% to 25% 
ethyl acetate in hexanes to give acetate S5 as a clear oil (2.60 g, 95% yield). 1H NMR (CDCl3, 500 MHz; compound exists as 
a 5.9:1 mixture of α and β anomers, the major anomer is denoted by *) δ 6.22 (1 H*, dd, J=3.4, 1.5 Hz), 5.67 (1 H, dd, 
J=10.0, 2.2 Hz), 3.70 (1 H*, ddd, J=9.8, 3.4, 2.0 Hz), 3.57 (3 H*, s), 3.55 (3 H, s), 3.53 - 3.65 (3 H* + 2 H, m), 3.46 (3 H*, 
s), 3.45 (3 H, s), 3.41 (3 H*, s), 3.40 (3 H, s), 3.35 - 3.43 (2 H, m), 3.26 (1 H*, dd, J=9.8 Hz), 3.21 (1 H, dd, J=9.3 Hz), 2.33 
(1 H, ddd, J=12.3, 5.0, 2.2 Hz), 2.24 (1 H*, ddd, J=13.6, 5.2, 1.7 Hz), 2.09 (3 H, s), 2.08 (3 H*, s), 1.69 (1 H*, ddd, J=13.7, 
11.2, 3.4 Hz), 1.55 - 1.63 (1 H, m); 13C NMR (CDCl3, 125 MHz; compound exists as a 5.9:1 mixture of α and β anomers, 
signals corresponding to the major anomer are provided) δ 169.5, 92.3, 79.5, 78.4, 73.4, 71.2, 60.8, 59.4, 57.5, 33.9, 21.3; 
FTIR (thin film, cm-1) 3616 (br), 3523 (br), 2980 (s), 2934 (s), 2831 (s), 1746 (s), 1447 (s), 1377 (s), 1237 (s), 1189 (s), 1129 
(s), 1073 (s), 1014 (s), 992 (s), 970 (s), 926 (s), 887 (m); HRMS (ES+) [M+K]+ calculated for C11H20KO6: 287.0892, Found: 
287.0898. 
 
General procedure for thiourea-catalyzed addition of methanol to of 3,4,6-tri-O-methyl-2-deoxy glycosyl acetate (SI 
Table 1, entries 1−3). 
 
O
H3CO
H3CO
OCH3
OAc O
H3CO
H3CO
OCH3
OCH3catalyst (10 mol%)
BCl3 (20 mol%)
CH3OH (1.5 equiv), 
TBME, −78 to −30 °C to rt
S5 (5.9:1 α/β) S6  
An oven-dried 1-dram vial containing a stir bar and fitted with a screw cap lid containing a Teflon septum was 
cooled under a nitrogen atmosphere. The vial was charged with thiourea catalyst (0.01 mmol, 10 mol%) and the vial was 
evacuated and backfilled with nitrogen. To the vial was added glycosyl acetate S5 (0.80 mL of a 0.125 M stock solution in 
TBME, 0.1 mmol, 1 equiv) and the solution was cooled to −78 °C (dry ice-acetone bath). Methanol (6mL, 0.15 mmol, 1.5 
equiv) was added via syringe, followed by BCl3 (20 mL, 1 M solution in hexanes, 0.02 mmol, 20 mol%). The vial was 
immediately transferred to a −30 °C immersion cooler and was maintained at that temperature for 48 hours. The reaction was 
warmed to room temperature over 10 minutes and filtered through a pipette containing 2 inches of silica gel and rinsed with 
10 mL of a 50% Et2O-Hexanes solution. The solvent was removed by rotary evaporation under reduced pressure to give the 
crude residue S6, which was analyzed by 1H NMR to determine the reaction conversion and diastereoselectivity. The 
                                                 
12 Prepared from D-Glucal based on the procedure reported in: Dunkerton, L. V.; Adair, N. K.; Euske, J. M.; Brady, K. T.; 
Robinson, P. D. J. Org. Chem. 1988, 53, 845−850. D-Glucal was prepared according to the literature procedure: Di Bussolo, 
V.; Caselli, M.; Pineschi, M.; Crotti, P. Org. Lett. 2003, 5, 2173−2176. 
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diastereomeric ratio of product was determined by 1H NMR integration (δH1,α  = 4.82 ppm, δH1,β = 4.35 ppm). The 
diastereomeric ratio of recovered starting material was determined by 1H NMR integration (δH1,α  = 6.22 ppm, δH1, β = 5.67 
ppm). 1H NMR (CDCl3, 500 MHz; compound exists as a mixture of α and β anomers, the major anomer is denoted by *) δ 
4.82 (1 H*, d, J=2.4 Hz), 4.35 (1 H, dd, J=9.8, 2.0 Hz), 3.55 - 3.69 (4 H* + 2 H, m), 3.54 (3 H*, s), 3.54 (3 H, s), 3.49 (3 H, 
s), 3.44 (3 H*, s), 3.43 (3 H, s), 3.43 (3 H*, s), 3.42 (3 H, s), 3.33 (3 H*, s), 3.24 - 3.34 ( 2 H, m), 3.16 (1 H*, dd, J=9.3 Hz), 
3.11 (1 H, dd, J=9.3 Hz), 2.30 (1 H, ddd, J=12.7, 5.4, 2.0 Hz), 2.22 (1 H*, ddd, J=13.1, 5.0, 1.5 Hz), 1.56 (1 H*, ddd, J=13.1, 
11.6, 3.7 Hz), 1.48 (1 H, ddd, J=12.2, 9.8 Hz); 13C NMR (CDCl3, 125 MHz; compound exists as a mixture of α and β 
anomers, signals corresponding to the major anomer are denoted by *) δ 101.0, 98.7*, 81.1, 80.1*, 79.8, 78.9*, 75.2, 71.9, 
71.6*, 70.6*, 60.7, 60.6*, 59.5, 59.4*, 57.4*, 57.1, 56.7, 54.8*, 36.1, 35.0*; FTIR (thin film, cm-1) 2977 (m), 2934 (s), 2896 
(s), 2832 (s), 1467 (m), 1447 (m), 1385 (m), 1214 (s), 1188 (s), 1128 (s), 1083 (s), 996 (m), 972 (s), 905 (m); HRMS (ES+) 
[M+Na]+ calculated for C10H2oNaO5: 243.1203, Found: 243.1223.  
 
 
 
 
  
 
 
 
